Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.
E Boerwinkle, … , G Chiesa, H H Hobbs
E Boerwinkle, … , G Chiesa, H H Hobbs
Published July 1, 1992
Citation Information: J Clin Invest. 1992;90(1):52-60. https://doi.org/10.1172/JCI115855.
View: Text | PDF
Research Article Article has an altmetric score of 13

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

  • Text
  • PDF
Abstract

Plasma lipoprotein(a) [Lp(a)], a low density lipoprotein particle with an attached apolipoprotein(a) [apo(a)], varies widely in concentration between individuals. These concentration differences are heritable and inversely related to the number of kringle 4 repeats in the apo(a) gene. To define the genetic determinants of plasma Lp(a) levels, plasma Lp(a) concentrations and apo(a) genotypes were examined in 48 nuclear Caucasian families. Apo(a) genotypes were determined using a newly developed pulsed-field gel electrophoresis method which distinguished 19 different genotypes at the apo(a) locus. The apo(a) gene itself was found to account for virtually all the genetic variability in plasma Lp(a) levels. This conclusion was reached by analyzing plasma Lp(a) levels in siblings who shared zero, one, or two apo(a) genes that were identical by descent (ibd). Siblings with both apo(a) alleles ibd (n = 72) have strikingly similar plasma Lp(a) levels (r = 0.95), whereas those who shared no apo(a) alleles (n = 52), had dissimilar concentrations (r = -0.23). The apo(a) gene was estimated to be responsible for 91% of the variance of plasma Lp(a) concentration. The number of kringle 4 repeats in the apo(a) gene accounted for 69% of the variation, and yet to be defined cis-acting sequences at the apo(a) locus accounted for the remaining 22% of the inter-individual variation in plasma Lp(a) levels. During the course of these studies we observed the de novo generation of a new apo(a) allele, an event that occurred once in 376 meioses.

Authors

E Boerwinkle, C C Leffert, J Lin, C Lackner, G Chiesa, H H Hobbs

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 Total
Citations: 8 18 16 11 21 23 17 13 14 23 20 21 10 14 21 13 17 16 9 11 13 16 23 27 24 24 43 30 43 33 36 45 18 1 692
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (692)

Title and authors Publication Year
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease
Kalwick M, Roth M
Nutrients 2025
Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
Sheashaa H, Mousa H, Abbas MT, Farina JM, Awad K, Pereyra M, Scalia IG, Ali NB, Javadi N, Bismee NN, Esfahani SA, Ibrahim O, Abdelfattah F, Ibrahim R, Abdelnabi M, Ayoub C, Arsanjani R
Biomolecules 2025
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening
Clair V, Zirille FM, Gill E
American Journal of Preventive Cardiology 2025
The Association between Lipoprotein(a) and Coronary Artery Calcification in Elderly Patients with Diabetes: A Cross-Sectional Study
Qiu L, Qiao H
Reviews in Cardiovascular Medicine 2025
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Khan TG, Cunha JB, Raut C, Burroughs M, Vyas HS, Leix K, Goonewardena SN, Smrcka AV, Speliotes EK, Emmer BT
Atherosclerosis 2025
Lipoprotein(a) and Risk of Incident Atherosclerotic Cardiovascular Disease: Impact of High-Sensitivity C-Reactive Protein and Risk Variability Among Human Clinical Subgroups
Hoogeveen RC, Diffenderfer MR, Lim E, Liu CT, Ikezaki H, Guan W, Tsai MY, Ballantyne CM
Nutrients 2025
Patient Experience of Heart Disease with Elevated Lipoprotein(a): Views from a Patient, His Physician, and a Patient Association.
Favereaux S, Durlach V, Vercoustre B
Cardiology and therapy 2025
2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings.
Sosnowska B, Toth PP, Razavi AC, Remaley AT, Blumenthal RS, Banach M
Archives of medical science : AMS 2025
Lipoprotein(a): from Causality to Treatment.
Kronenberg F
Current Atherosclerosis Reports 2024
Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.
Sosnowska B, Stepinska J, Mitkowski P, Bielecka-Dabrowa A, Bobrowska B, Budzianowski J, Burchardt P, Chlebus K, Dobrowolski P, Gasior M, Jankowski P, Kubica J, Mickiewicz A, Mysliwiec M, Osadnik T, Prejbisz A, Rajtar-Salwa R, Wita K, Witkowski A, Gil R, Banach M
Archives of Medical Science : AMS 2024
Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization
Barbieri G, Cassioli G, Kura A, Orsi R, Magi A, Berteotti M, Scaturro GM, Lotti E, Gori AM, Marcucci R, Giusti B, Sticchi E
Journal of Clinical Laboratory Analysis 2024
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial.
Nissen SE, Wolski K, Watts GF, Koren MJ, Fok H, Nicholls SJ, Rider DA, Cho L, Romano S, Melgaard C, Rambaran C
Journal of the American Medical Association 2024
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Khan TG, Cunha JB, Raut C, Burroughs M, Goonewardena SN, Smrcka AV, Speliotes EK, Emmer BT
2024
Measuring Lp(a) particles with a novel isoform-insensitive immunoassay demonstrates potent efficacy of muvalaplin
Craig Swearingen, John Sloan, Grace M. Rhodes, Robert W. Siegel, Nico Bivi, Yuewei Qian, Robert Konrad, Michael Boffa, Marlys Koschinsky, John Krege, Giacomo Ruotolo, Stephen Nicholls, Laura Michael, Yi Wen
Journal of lipid research 2024
Highlighting the South Asian Heart Failure Epidemic.
Srinivasan N, Gullapalli N, Shah KS
Cardiac Failure Review 2024
Lipoprotein(a) and diet: consuming sugar-sweetened beverages lowers lipoprotein(a) levels in obese and overweight adults
Law HG, Stanhope KL, Zhang W, Myagmarsuren M, Jamshed ZM, Khan MA, Bang H, Havel PJ, Berglund L, Enkhmaa B
Journal of Lipid Research 2024
Therapeutic Gene Editing in Dyslipidemias
Tamehri Zadeh SS, Shapiro MD
Reviews in Cardiovascular Medicine 2024
Lipoprotein (a) and the Occurrence of Lipid Disorders and Other Cardiovascular Risk Factors in Patients without Diagnosed Cardiovascular Disease
Ratajczak J, Kubica A, Pietrzykowski Ł, Michalski P, Kosobucka-Ozdoba A, Buczkowski K, Krintus M, Jankowski P, Kubica J
Journal of Clinical Medicine 2024
Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk.
Mukherjee D, Nissen SE
Current vascular pharmacology 2024
Nanopore sequencing with unique molecular identifiers enables accurate mutation analysis and haplotyping in the complex lipoprotein(a) KIV-2 VNTR.
Amstler S, Streiter G, Pfurtscheller C, Forer L, Di Maio S, Weissensteiner H, Paulweber B, Schönherr S, Kronenberg F, Coassin S
Genome medicine 2024
Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder.
Annink ME, Janssen ES, Reeskamp LF
Current opinion in lipidology 2024
A scalable adaptive quadratic kernel method for interpretable epistasis analysis in complex traits.
Fu B, Anand P, Anand A, Mefford J, Sankararaman S
Genome research 2024
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Nissen SE, Wang Q, Nicholls SJ, Navar AM, Ray KK, Schwartz GG, Szarek M, Stroes ES, Troquay R, Dorresteijn JA, Fok H, Rider DA, Romano S, Wolski K, Rambaran C
JAMA 2024
Lipoprotein (a): Underrecognized Risk with a Promising Future
Manzato M, Wright RS, Jaffe AS, Vasile VC
Reviews in Cardiovascular Medicine 2024
Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition
Andersen CJ, Fernandez ML
Nutrients 2024
Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History
Tada H, Kojima N, Yamagami K, Takeji Y, Sakata K, Usui S, Kawashiri MA, Takamura M
Journal of Lipid and Atherosclerosis 2024
Genome Editing in Dyslipidemia and Atherosclerosis.
Chen Z, Lehertshuber C, Schunkert H
Advances in experimental medicine and biology 2023
Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort.
Matveyenko A, Matienzo N, Ginsberg H, Nandakumar R, Seid H, Ramakrishnan R, Holleran S, Thomas T, Reyes-Soffer G
Journal of lipid research 2023
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors
Levstek T, Karun T, Rehberger Likozar A, Šebeštjen M, Trebušak Podkrajšek K
Genes & development 2023
Genetics of aortic valve disease.
Ackah RL, Yasuhara J, Garg V
Current Opinion in Cardiology 2023
Relationship between lipoprotein(a) levels, cardiovascular outcomes and death in patients with chronic kidney disease: a systematic review of prospective studies.
Barbagelata L, Masson W, Corral P, Lavalle-Cobo A, Nogueira JP, Rosa Diez G
Journal of Nephrology 2023
Lipoprotein (a), Inflammation, and Atherosclerosis.
Di Fusco SA, Maggioni AP, Scicchitano P, Zuin M, D'Elia E, Colivicchi F
Journal of Clinical Medicine 2023
Lipoprotein (a): Does It Play a Role in Pediatric Ischemic Stroke and Thrombosis?
Torres M, Schenk A
Current Atherosclerosis Reports 2023
Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors.
Likozar AR, Šebeštjen M
Cardiovascular ultrasound 2023
Lipoprotein(a) and diet-a challenge for a role of saturated fat in cardiovascular disease risk reduction?
Law HG, Meyers FJ, Berglund L, Enkhmaa B
The American journal of clinical nutrition 2023
Reducing saturated fat intake lowers LDL-C but increases Lp(a) levels in African Americans: the GET-READI feeding trial.
Law HG, Khan MA, Zhang W, Bang H, Rood J, Most M, Lefevre M, Berglund L, Enkhmaa B
Journal of lipid research 2023
Association of free-living diet composition with plasma lipoprotein(a) levels in healthy adults.
Matveyenko A, Seid H, Kim K, Ramakrishnan R, Thomas T, Matienzo N, Reyes-Soffer G
Lipids in Health and Disease 2023
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?
Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P, Bulfone L, Vacca A, Bertin N, Vivarelli C, Comand J, Catena C, Sechi LA
International journal of molecular sciences 2023
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.
Vinci P, Di Girolamo FG, Panizon E, Tosoni LM, Cerrato C, Pellicori F, Altamura N, Pirulli A, Zaccari M, Biasinutto C, Roni C, Fiotti N, Schincariol P, Mangogna A, Biolo G
International journal of environmental research and public health 2023
Concordance of a High Lipoprotein(a) Concentration Among Relatives.
Reeskamp LF, Tromp TR, Patel AP, Ibrahim S, Trinder M, Haidermota S, Hovingh GK, Stroes ESG, Natarajan P, Khera AV
JAMA Cardiology 2023
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial.
Nissen SE, Linnebjerg H, Shen X, Wolski K, Ma X, Lim S, Michael LF, Ruotolo G, Gribble G, Navar AM, Nicholls SJ
Journal of the American Medical Association 2023
Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
Gilliland TC, Liu Y, Mohebi R, Miksenas H, Haidermota S, Wong M, Hu X, Cristino JR, Browne A, Plutzky J, Tsimikas S, Januzzi JL Jr, Natarajan P
Journal of the American College of Cardiology 2023
Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.
Coassin S, Chemello K, Khantalin I, Forer L, Döttelmayer P, Schönherr S, Grüneis R, Chong-Hong-Fong C, Nativel B, Ramin-Mangata S, Gallo A, Roche M, Muelegger B, Gieger C, Peters A, Zschocke J, Marimoutou C, Meilhac O, Lamina C, Kronenberg F, Blanchard V, Lambert G
Circulation. Genomic and precision medicine 2022
Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
Clark JR, Gemin M, Youssef A, Marcovina SM, Prat A, Seidah NG, Hegele RA, Boffa MB, Koschinsky ML
Journal of lipid research 2022
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics.
Swerdlow DI, Rider DA, Yavari A, Wikström Lindholm M, Campion GV, Nissen SE
Cardiovascular Research 2022
Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk.
Trinder M, Paruchuri K, Haidermota S, Bernardo R, Zekavat SM, Gilliland T, Januzzi J Jr, Natarajan P
Journal of the American College of Cardiology 2022
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
Alonso R, Argüeso R, Álvarez-Baños P, Muñiz-Grijalvo O, Diaz-Diaz JL, Mata P
Current Atherosclerosis Reports 2022
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
Coassin S, Kronenberg F
Atherosclerosis 2022
A method for lipoprotein (a) Isolation from a small volume of plasma with applications for clinical research.
Mueller PA, Yerkes E, Bergstrom P, Rosario S, Hay J, Pamir N
Scientific Reports 2022
Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome.
Kato A, Kinoshita D, Nagata T, Asakura K, Katamine M, Katsura A, Hashimoto T, Minami Y, Ako J
2022
A Modern Approach to Dyslipidemia.
Berberich AJ, Hegele RA
Endocrine reviews 2022
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
Nissen SE, Wolski K, Balog C, Swerdlow DI, Scrimgeour AC, Rambaran C, Wilson RJ, Boyce M, Ray KK, Cho L, Watts GF, Koren M, Turner T, Stroes ES, Melgaard C, Campion GV
Journal of the American Medical Association 2022
Glucose metabolism status modifies the relationship between lipoprotein(a) and carotid plaques in individuals with fatty liver disease.
Wang J, Sun H, Wang Y, An Y, Liu J, Wang G
Frontiers in Endocrinology 2022
Genetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and “Missing” Heritability
JM Martín-Campos
Biomedicines 2021
Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation
G Reyes-Soffer, M Westerterp
Pharmacological research : the official journal of the Italian Pharmacological Society 2021
Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer
SP Wyness, JR Genzen
Practical Laboratory Medicine 2021
Protein-coding repeat polymorphisms strongly shape diverse human phenotypes
RE Mukamel, RE Handsaker, MA Sherman, AR Barton, Y Zheng, SA McCarroll, PR Loh
Science 2021
Lipoprotein (a): When to Measure and How to Treat?
D Rhainds, MR Brodeur, JC Tardif
Current Atherosclerosis Reports 2021
Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease
M Trinder, M Uddin, P Finneran, KG Aragam, P Natarajan
JAMA Cardiology 2021
Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen
E Karwatowska-Prokopczuk, N Clouet-Foraison, S Xia, NJ Viney, JL Witztum, SM Marcovina, S Tsimikas
Atherosclerosis 2021
A review on clotting disorders and retinal hemorrhages: Can they mimic abuse?
A Thau, B Saffren, JD Anderst, SL Carpenter, AV Levin
Child Abuse & Neglect 2021
Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank
E Widen, TG Raben, L Lello, SD Hsu
Genes & development 2021
Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health?
D Yannas, F Frizza, L Vignozzi, G Corona, M Maggi, G Rastrelli
Journal of Clinical Medicine 2021
The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk
G Reyes-Soffer
Current Opinion in Lipidology 2021
Lipid Optimization in Lower Extremity Peripheral Arterial Disease
PP Sucharitkul, KL Jones, DJ Scott, MA Bailey
Annals of Vascular Surgery 2021
Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis
P Kumar, P Swarnkar, S Misra, M Nath
Scientific Reports 2021
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study
M Arnold, J Schweizer, CT Nakas, V Schütz, LP Westphal, C Inauen, T Pokorny, A Luft, A Leichtle, M Arnold, A Bicvic, U Fischer, GM Marchis, LH Bonati, MD Müller, T Kahles, K Nedeltchev, CW Cereda, G Kägi, A Bustamante, J Montaner, G Ntaios, C Foerch, K Spanaus, A von Eckardstein, M Katan
European Heart Journal 2021
Cardiovascular Disease in Racial and Ethnic Minority Populations
KC Ferdinand, HA Taylor, CJ Rodriguez
2021
Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation
V Marco-Benedí, A Cenarro, M Laclaustra, A Larrea-Sebal, E Jarauta, I Lamiquiz-Moneo, P Calmarza, AM Bea, N Plana, X Pintó, C Martín, F Civeira
Atherosclerosis 2021
Blood biomarker levels by total sleep duration: cross-sectional analyses in UK Biobank
TY Wong, RC Travis, TY Tong
Sleep Medicine 2021
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
DI Swerdlow, DA Rider, A Yavari, MW Lindholm, GV Campion, SE Nissen
Cardiovascular Research 2021
Lipoprotein(a) Levels at Birth and in Early Childhood: The COMPARE Study
N Strandkjær, MK Hansen, ST Nielsen, R Frikke-Schmidt, A Tybjærg-Hansen, BG Nordestgaard, A Tabor, H Bundgaard, K Iversen, PR Kamstrup
The Journal of clinical endocrinology and metabolism 2021
Proteomic studies on apoB‐containing lipoprotein in cardiovascular research: A comprehensive review
E Gianazza, B Zoanni, A Mallia, M Brioschi, GI Colombo, C Banfi
Mass Spectrometry Reviews 2021
Changes of lipoprotein(a) levels with endogenous steroid hormones
E Tessitore, K Dobretz, NA Dhayat, I Kern, B Ponte, M Pruijm, D Ackermann, S Estoppey, M Burnier, PY Martin, B Vogt, N Vuilleumier, M Bochud, F Mach, G Ehret
European Journal of Clinical Investigation 2021
A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter
S Coassin, N Hermann-Kleiter, M Haun, S Wahl, R Wilson, B Paulweber, S Kunze, T Meitinger, K Strauch, A Peters, M Waldenberger, F Kronenberg, C Lamina, DC Crawford
PloS one 2020
Acute and Chronic Impact of Biliopancreatic Diversion with Duodenal Switch Surgery on Plasma Lipoprotein(a) Levels in Patients with Severe Obesity
AA Després, ME Piché, A Auclair, L Biertho, S Marceau, FS Hould, S Biron, S Lebel, O Lescelleur, F Julien, J Martin, A Tchernof, P Mathieu, P Poirier, BJ Arsenault
Obesity Surgery 2020
DNA methylation profiling identifies a high effect genetic variant for lipoprotein(a) levels
GT Jones, J Marsman, B Bhat, VL Phillips, A Chatterjee, EJ Rodger, MJ Williams, AM van Rij, SP McCormick
Epigenetics : official journal of the DNA Methylation Society 2020
Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia
M Trinder, ML DeCastro, H Azizi, L Cermakova, LM Jackson, J Frohlich, GB Mancini, GA Francis, LR Brunham
Journal of the American College of Cardiology 2020
Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
AR Likozar, M Zavrtanik, M Šebeštjen
Annals of Medicine 2020
Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals
SD Maio, R Grüneis, G Streiter, C Lamina, M Maglione, S Schoenherr, D Öfner, B Thorand, A Peters, KU Eckardt, A Köttgen, F Kronenberg, S Coassin
Genome Medicine 2020
PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability
B Enkhmaa, K Kim, W Zhang, N Prakash, K Truax, E Anuurad, L Berglund
Journal of the Endocrine Society 2020
The Prevalence of Elevated Lipoprotein(a) in Patients Presenting With Coronary Artery Disease
HP Oo, J Giovannucci, RC OBrien, DL Hare
Heart, lung & circulation 2020
Plasma lipoprotein(a) concentration as an independent predictor of hemodynamic progression of aortic valve stenosis
VD Tomova, ML Alexandrova, MA Atanasova, ML Tzekova, TR Rashev, S Ahmad
Molecular and Cellular Biochemistry 2020
Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease
I Jung, H Kwon, SE Park, CY Park, WY Lee, KW Oh, SW Park, EJ Rhee
Atherosclerosis 2020
Papel de los lípidos en la ateroesclerosis
F Civeira, V Marco-Benedí, A Cenarro
Revista Española de Cardiología Suplementos 2020
The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease in Healthy Individuals: A Review of Human Intervention Trials
E Froyen, B Burns-Whitmore
Nutrients 2020
The role of Lipoprotein(a) in cardiovascular disease: Current concepts and future perspectives
MA Vavuranakis, SR Jones, R Cardoso, G Gerstenblith, TM Leucker
HELL J CARDIOL 2020
Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
MA Kachkovsky, IP Vvedenskaya, VY Vvedensky, AA Supilnikov, JV Ponomareva, MN Milyakova
2020
Serum Lipoprotein (a) on Postoperative Day 3: A Strong Predictor of Portal and/or Splenic Vein Thrombosis in Cirrhotic Patients With Splenectomy
Z Shi, M Zhang, X Dong, J Xu
Clinical and Applied Thrombosis/Hemostasis 2020
Prevalence and status of Lipoprotein (a) among Lebanese school children
MH Gannagé-Yared, C Lahoud, N Younes, R Chedid, G Sleilaty
Scientific Reports 2020
Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study
F Moosaie, RM Davatgari, FD Firouzabadi, S Esteghamati, N Deravi, A Meysamie, P Khaloo, M Nakhjavani, A Esteghamati
Canadian Journal of Diabetes 2020
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
CA German, MD Shapiro
European Cardiology Review 2020
Type 1 diabetes mellitus, familial hypercholesterolemia, and elevated lipoprotein (a)
L Hamilton, C McNeal, D Wilson
Proceedings (Baylor University. Medical Center) 2020
Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels
M Hoekstra, HY Chen, J Rong, L Dufresne, J Yao, X Guo, MY Tsai, S Tsimikas, WS Post, RS Vasan, JI Rotter, MG Larson, G Thanassoulis, JC Engert
Arteriosclerosis, thrombosis, and vascular biology 2020
Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT)
LT Appiah, FS Sarfo, SB Nguah, MD Huffman, JK Stiles, MJ Feinstein
Global Heart 2020
Lipoprotein(a) and its Clinical Importance
FZ avval, malihe Moammeri Salahshooh,
2020
Plasma lipoprotein(a) concentration as an independent predictor of hemodynamic progression of aortic valve stenosis.
Tomova VD, Alexandrova ML, Atanasova MA, Tzekova ML, Rashev TR, Ahmad S
Molecular and Cellular Biochemistry 2020
Nucleic Acid Therapies for Ischemic Stroke
N Henninger, Y Mayasi
Neurotherapeutics 2019
The Role of (Modified) Lipoproteins in Vascular Function: A Duet Between Monocytes and the Endothelium
JG Schnitzler, GM Dallinga-Thie, J Kroon
Current medicinal chemistry 2019
The Future of Lipid-lowering Therapy
Zwol, Rimbert, Kuivenhoven
Journal of Clinical Medicine 2019
Risk factors for valvular calcification:
HY Chen, JC Engert, G Thanassoulis
Current opinion in endocrinology, diabetes, and obesity 2019
Dietary natural products as emerging lipoprotein(a)-lowering agents: MOMTAZI-BOROJENI et al
AA Momtazi-Borojeni, N Katsiki, M Pirro, M Banach, KA Rasadi, A Sahebkar
Journal of Cellular Physiology 2019
Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
H Tada, M Takamura, M Kawashiri
Journal of Atherosclerosis and Thrombosis 2019
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels
G Cai, Z Huang, B Zhang, L Yu, L Li
Bioscience Reports 2019
Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families
B Enkhmaa, E Anuurad, W Zhang, K Kim, L Berglund
Journal of lipid research 2019
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults
MT Mefford, SM Marcovina, V Bittner, M Cushman, TM Brown, ME Farkouh, S Tsimikas, KL Monda, JA López, P Muntner, RS Rosenson
Journal of lipid research 2019
Laboratory medicine: health evaluation in elite athletes
B Lombardo, V Izzo, D Terracciano, A Ranieri, C Mazzaccara, F Fimiani, A Cesaro, L Gentile, E Leggiero, R Pero, B Izzo, AC DAlicandro, D Ercolini, G DAlicandro, G Frisso, L Pastore, P Calabrò, O Scudiero
Clinical Chemistry and Laboratory Medicine 2019
Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options
AN Berman, R Blankstein
Current Cardiology Reports 2019
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives
MF Wu, KZ Xu, YG Guo, J Yu, Y Wu, LM Lin
Cardiovascular Drugs and Therapy 2019
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
DF Gudbjartsson, G Thorgeirsson, P Sulem, A Helgadottir, A Gylfason, J Saemundsdottir, E Bjornsson, GL Norddahl, A Jonasdottir, A Jonasdottir, HP Eggertsson, S Gretarsdottir, G Thorleifsson, OS Indridason, R Palsson, F Jonasson, I Jonsdottir, GI Eyjolfsson, O Sigurdardottir, I Olafsson, R Danielsen, SE Matthiasson, S Kristmundsdottir, BV Halldorsson, AB Hreidarsson, EM Valdimarsson, T Gudnason, R Benediktsson, V Steinthorsdottir, U Thorsteinsdottir, H Holm, K Stefansson
Journal of the American College of Cardiology 2019
Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype
R Yahya, K Berk, A Verhoeven, S Bos, L van der Zee, J Touw, G Erhart, F Kronenberg, R Timman, E Sijbrands, JR van Lennep, M Mulder
Atherosclerosis 2019
LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia
M Paquette, S Bernard, G Thanassoulis, A Baass
Journal of Clinical Lipidology 2019
Nonsynonymous SNPs in LPA homologous to plasminogen deficiency mutants represent novel null apo(a) alleles
BM Morgan, AN Brown, N Deo, TW Harrop, G Taiaroa, PD Mace, SM Wilbanks, TR Merriman, MJ Williams, SP McCormick
Journal of lipid research 2019
Comparison of Coronary Atherosclerotic Plaque Burden and Composition as Assessed on Coronary Computed Tomography Angiography in East Asian and European-Origin Caucasians
AR Ihdayhid, M Goeller, D Dey, N Nerlekar, G Yap, U Thakur, D Adams, J Cameron, S Seneviratne, S Achenbach, B Ko
The American Journal of Cardiology 2019
Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks
RS Najjar, CE Moore, BD Montgomery
Clinical Cardiology 2018
Establishing age and sex dependent upper reference limits for the plasma lipoprotein (a) in a Chinese health check-up population and according to its relative risk of primary myocardial infarction
FM Cui, F Fang, YM He, DP Cai, J He, XJ Yang
Clinica chimica acta; international journal of clinical chemistry 2018
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis
S Burgess, BA Ference, JR Staley, DF Freitag, AM Mason, SF Nielsen, P Willeit, R Young, P Surendran, S Karthikeyan, TR Bolton, JE Peters, PR Kamstrup, A Tybjærg-Hansen, M Benn, A Langsted, P Schnohr, S Vedel-Krogh, CJ Kobylecki, I Ford, C Packard, S Trompet, JW Jukema, N Sattar, ED Angelantonio, D Saleheen, JM Howson, BG Nordestgaard, AS Butterworth, J Danesh
JAMA Cardiology 2018
Apolipoprotein(a) is the Product of a Pseudogene: Implications for the Pathophysiology of Lipoprotein(a)
GD Sloop, G Pop, JJ Weidman, JA Cyr
Cureus 2018
Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records
HY Chen, L Dufresne, H Burr, A Ambikkumar, N Yasui, K Luk, DK Ranatunga, RA Whitmer, M Lathrop, JC Engert, G Thanassoulis
JAMA Cardiology 2018
Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women’s Interagency HIV Study
B Enkhmaa, E Anuurad, W Zhang, CS Li, R Kaplan, J Lazar, D Merenstein, R Karim, B Aouizerat, M Cohen, K Butler, S Pahwa, I Ofotokun, AA Adimora, E Golub, L Berglund
Journal of lipid research 2018
Contextualizing selection bias in Mendelian randomization: how bad is it likely to be?
A Gkatzionis, S Burgess
International Journal of Epidemiology 2018
In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members
AW Zawacki, A Dodge, KM Woo, JC Ralphe, AL Peterson
Journal of Clinical Lipidology 2018
Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment Options
BA Ference
Clinical Pharmacology & Therapeutics 2018
A comprehensive map of single-base polymorphisms in the hypervariable LPA kringle IV type 2 copy number variation region
S Coassin, S Schönherr, H Weissensteiner, G Erhart, L Forer, JL Losso, C Lamina, M Haun, G Utermann, B Paulweber, G Specht, F Kronenberg
Journal of lipid research 2018
Heart Genomics
H Jiang, M Liu
2018
Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors
S Stanner, S Coe, KN Frayn
2018
Lipids in Children and Links to Adult Vascular Disease
John C Coakley
The Clinical Biochemist Reviews 2018
The metabolism of lipoprotein (a): an ever-evolving story
G Reyes-Soffer, HN Ginsberg, R Ramakrishnan
Journal of lipid research 2017
Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes
KA Berk, R Yahya, AJ Verhoeven, J Touw, FP Leijten, EF van Rossum, VL Wester, MA Lips, H Pijl, R Timman, G Erhart, F Kronenberg, JE van Lennep, EJ Sijbrands, MT Mulder
Diabetologia 2017
Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
R Romagnuolo, CA Scipione, SM Marcovina, M Gemin, NG Seidah, MB Boffa, ML Koschinsky, MC Vinci
PloS one 2017
Male Hypogonadism
SJ Winters, IT Huhtaniemi
Male Hypogonadism 2017
Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease
JG Smith, RE Gerszten
Circulation 2017
Pathobiology of Lp(a) in calcific aortic valve disease
P Mathieu, BJ Arsenault, MC Boulanger, Y Bossé, ML Koschinsky
Expert Review of Cardiovascular Therapy 2017
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk
BJ Arsenault, F Petrides, F Tabet, W Bao, GK Hovingh, SM Boekholdt, S Ramin-Mangata, O Meilhac, D DeMicco, KA Rye, DD Waters, JJ Kastelein, P Barter, G Lambert
Journal of Clinical Lipidology 2017
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
S Mack, S Coassin, R Rueedi, NA Yousri, I Seppälä, C Gieger, S Schönherr, L Forer, G Erhart, P Marques-Vidal, JS Ried, G Waeber, S Bergmann, D Dähnhardt, A Stöckl, OT Raitakari, M Kähönen, A Peters, T Meitinger, K Strauch, L Kedenko, B Paulweber, T Lehtimäki, SC Hunt, P Vollenweider, C Lamina, F Kronenberg
Journal of lipid research 2017
Lipoprotein(a) and HIVHighlights: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima–Media Thickness in HIV-Infected Young Women in the Women’s Interagency HIV Study
B Enkhmaa, E Anuurad, W Zhang, CS Li, R Kaplan, J Lazar, D Merenstein, R Karim, B Aouizerat, M Cohen, K Butler, S Pahwa, I Ofotokun, AA Adimora, E Golub, L Berglund
Arteriosclerosis, thrombosis, and vascular biology 2017
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study
N Perrot, R Verbeek, M Sandhu, SM Boekholdt, GK Hovingh, NJ Wareham, KT Khaw, BJ Arsenault
Atherosclerosis 2017
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
S Zewinger, ME Kleber, V Tragante, RO McCubrey, AF Schmidt, K Direk, U Laufs, C Werner, W Koenig, D Rothenbacher, U Mons, LP Breitling, H Brenner, RT Jennings, I Petrakis, S Triem, M Klug, A Filips, S Blankenberg, C Waldeyer, C Sinning, RB Schnabel, KJ Lackner, E Vlachopoulou, O Nygård, GF Svingen, ER Pedersen, GS Tell, J Sinisalo, MS Nieminen, R Laaksonen, S Trompet, RA Smit, N Sattar, JW Jukema, HV Groesdonk, G Delgado, T Stojakovic, AP Pilbrow, VA Cameron, AM Richards, RN Doughty, Y Gong, R Cooper-DeHoff, J Johnson, M Scholz, F Beutner, J Thiery, JG Smith, RO Vilmundarson, R McPherson, AF Stewart, S Cresci, PA Lenzini, JA Spertus, O Olivieri, D Girelli, NI Martinelli, A Leiherer, CH Saely, H Drexel, A Mündlein, PS Braund, CP Nelson, NJ Samani, D Kofink, IE Hoefer, G Pasterkamp, AA Quyyumi, YA Ko, JA Hartiala, H Allayee, WH Tang, SL Hazen, N Eriksson, C Held, E Hagström, L Wallentin, A Åkerblom, A Siegbahn, I Karp, C Labos, L Pilote, JC Engert, JM Brophy, G Thanassoulis, P Bogaty, W Szczeklik, M Kaczor, M Sanak, SS Virani, CM Ballantyne, VV Lee, E Boerwinkle, MV Holmes, BD Horne, A Hingorani, FW Asselbergs, RS Patel, BK Krämer, H Scharnagl, D Fliser, W März, T Speer
The Lancet Diabetes & Endocrinology 2017
Lp(a) in Childhood
CJ Prendergast, JC Kelley, EF Linton, MR Linton
Current Cardiovascular Risk Reports 2017
Lipoprotein(a): new insights from modern genomics
M Afshar, G Thanassoulis
Current Opinion in Lipidology 2017
Inverse Association of Lipoprotein (a) With Markers of Insulin Resistance in Dyslipidemic Subjects
H Vaverková, D Karásek, M Halenka, L Cibíčková, V Kubíčková
Physiological research / Academia Scientiarum Bohemoslovaca 2017
Genetic markers: Potential candidates for cardiovascular disease
RA Rather, V Dhawan
International Journal of Cardiology 2016
Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions
O Bilen, A Kamal, SS Virani
World journal of cardiology 2016
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease
EA Stein, F Raal
Cardiovascular Drugs and Therapy 2016
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
F Kronenberg
Cardiovascular Drugs and Therapy 2016
Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis
C Yeang, B Cotter, S Tsimikas
Cardiovascular Drugs and Therapy 2016
Plasma lipoprotein(a) predicts major cardiovascular events in patients with chronic kidney disease who undergo percutaneous coronary intervention
H Konishi, K Miyauchi, S Tsuboi, M Ogita, R Naito, T Dohi, T Kasai, H Tamura, S Okazaki, K Isoda, H Daida
International Journal of Cardiology 2016
Structure, function, and genetics of lipoprotein (a)
K Schmidt, A Noureen, F Kronenberg, G Utermann
Journal of lipid research 2016
Searching for a common mechanism for placenta-mediated pregnancy complications and cardiovascular disease: role of lipoprotein(a)
I Romagnuolo, E Sticchi, M Attanasio, E Grifoni, G Cioni, AP Cellai, R Abbate, C Fatini
Fertility and Sterility 2016
A Case-Control Study of the Relationship Between SLC22A3-LPAL2-LPA Gene Cluster Polymorphism and Coronary Artery Disease in the Han Chinese Population
ZK Song, HY Cao, HD Wu, LT Zhou, L Qin
Iranian Red Crescent Medical Journal 2016
Lipoprotein(a) and Increased Cardiovascular Risk in Women: Lp(a) and increased CVD risk in women
BT Costello, ER Silverman, R Doukky, LT Braun, NT Aggarwal, Y Deng, Y Li, G Lundberg, KA Williams, AS Volgman
Clinical Cardiology 2016
Recurrent Embolic Strokes of Undetermined Source in a Patient with Extreme Lipoprotein(a) Levels
Z Bulwa, A Kim, K Singh, A Kantorovich, F Suhail
Frontiers in neurology 2016
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study
F Fogacci, AF Cicero, S D'Addato, L D'Agostini, M Rosticci, M Giovannini, E Bertagnin, C Borghi
European Journal of Internal Medicine 2016
Lipoprotein(a) and risk of sudden cardiac death in middle-aged Finnish men: A new prospective cohort study
SK Kunutsor, H Khan, K Nyyssönen, JA Laukkanen
International Journal of Cardiology 2016
Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
M Banach
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2016
Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)
M Afshar, L Pilote, L Dufresne, JC Engert, G Thanassoulis
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2016
Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black IndividualsSignificance: The Multi-Ethnic Study of Atherosclerosis
J Cao, BT Steffen, M Budoff, WS Post, G Thanassoulis, B Kestenbaum, JP McConnell, R Warnick, W Guan, MY Tsai
Arteriosclerosis, thrombosis, and vascular biology 2016
Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study
R Verbeek, SM Boekholdt, RM Stoekenbroek, GK Hovingh, JL Witztum, NJ Wareham, MS Sandhu, KT Khaw, S Tsimikas
Journal of lipid research 2016
Ischemic stroke in a young adult with extremely elevated lipoprotein(a): A case report and review of literature
D Lakshminarayan, TK Elajami, S Devabhaktuni, FK Welty
Journal of Clinical Lipidology 2016
Impact of Lipoprotein(a) on Long-term Outcomes in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
H Konishi, K Miyauchi, J Shitara, H Endo, H Wada, S Doi, R Naito, S Tsuboi, M Ogita, T Dohi, T Kasai, S Okazaki, K Isoda, S Suwa, H Daida
The American Journal of Cardiology 2016
The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis
J Hurtubise, K McLellan, K Durr, O Onasanya, D Nwabuko, JF Ndisang
Current Atherosclerosis Reports 2016
Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease
MB Boffa
Current Atherosclerosis Reports 2016
Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke
XW Hong, DM Wu, J Lu, YL Zheng, WJ Tu, J Yan
Molecular Neurobiology 2016
STUDY OF LIPOPROTEIN (A) LEVELS AS A RISK FACTOR IN PATIENTS WITH ESSENTIAL HYPERTENSION IN A TERTIARY CARE HOSPITAL
AS Menon, V V.S, N V, L Madhavan
2016
Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor
R Romagnuolo, CA Scipione, MB Boffa, SM Marcovina, NG Seidah, ML Koschinsky
The Journal of biological chemistry 2015
Rhesus monkey ( Macaca mulatta ) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms
B Enkhmaa, A Abbuthalha, E Anuurad, W Zhang, AF Tarantal, L Berglund
Journal of Medical Primatology 2015
Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment: The Multi-Ethnic Study of Atherosclerosis
W Guan, J Cao, BT Steffen, WS Post, JH Stein, MC Tattersall, JD Kaufman, JP McConnell, DM Hoefner, R Warnick, MY Tsai
Arteriosclerosis, thrombosis, and vascular biology 2015
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
N Müller, DM Schulte, K Türk, S Freitag-Wolf, J Hampe, R Zeuner, JO Schröder, I Gouni-Berthold, HK Berthold, W Krone, S Rose-John, S Schreiber, M Laudes
Journal of lipid research 2015
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state
C Catena
World Journal of Nephrology 2015
High Lipoprotein(a) Concentrations Are Associated with Impaired Endothelial Function in Children
J Lapinleimu, OT Raitakari, H Lapinleimu, K Pahkala, T Rönnemaa, OG Simell, JS Viikari
The Journal of Pediatrics 2015
New and Emerging Biomarkers in Cardiovascular Disease
LE Cahill, ML Bertoia, SA Aroner, KJ Mukamal, MK Jensen
Current Diabetes Reports 2015
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study
J Li, LA Lange, J Sabourin, Q Duan, W Valdar, MS Willis, Y Li, JG Wilson, EM Lange
Journal of Human Genetics 2015
Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People – Data from the Berlin Aging Study II
N Buchmann, U Kassner, K Norman, D Goldeck, R Eckardt, G Pawelec, E Steinhagen-Thiessen, I Demuth, CM Schooling
PloS one 2015
Quantitative variability of 342 plasma proteins in a human twin population
Y Liu, A Buil, BC Collins, LC Gillet, LC Blum, LY Cheng, O Vitek, J Mouritsen, G Lachance, TD Spector, ET Dermitzakis, R Aebersold
Molecular Systems Biology 2015
Distinct Metabolism of Apolipoproteins (a) and B-100 within Plasma Lipoprotein(a)
MR Diffenderfer, S Lamon-Fava, SM Marcovina, PH Barrett, J Lel, GG Dolnikowski, L Berglund, EJ Schaefer
Metabolism 2015
Lipoprotein (a) is a risk factor for coronary artery disease in Chinese Han ethnic population modified by some traditional risk factors: A cross-sectional study of 3462 cases and 6125 controls
DP Cai, YM He, XJ Yang, X Zhao, HF Xu
Clinica Chimica Acta 2015
Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians
M Khalifa, A Noureen, K Ertelthalner, AR Bandegi, R Delport, WJ Firdaus, FS Geethanjali, K Luthra, O Makemaharn, RW Pang, AH Salem, J Sasaki, W Schiefenhoevel, A Lingenhel, F Kronenberg, G Utermann, K Schmidt
Atherosclerosis 2015
A sense of excitement for a specific Lp(a)-lowering therapy
ES Stroes, FM van der Valk
The Lancet 2015
Lipoprotein(a): Its relevance to the pediatric population
CJ McNeal
Journal of Clinical Lipidology 2015
Lipoprotein (a): impact by ethnicity and environmental and medical conditions
B Enkhmaa, E Anuurad, L Berglund
Journal of lipid research 2015
Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans
MJ Graham, N Viney, RM Crooke, S Tsimikas
Journal of lipid research 2015
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
MB Boffa, ML Koschinsky
Journal of lipid research 2015
Combination Therapy In Dyslipidemia
M Banach
2015
Dyslipidemias: Pathophysiology, Evaluation and Management
A Garg
2015
Recent advances in physiological lipoprotein metabolism
I Ramasamy
Clinical Chemistry and Laboratory Medicine 2014
Novel metabolic biomarkers of cardiovascular disease
MK Jensen, ML Bertoia, LE Cahill, I Agarwal, EB Rimm, KJ Mukamal
Nature Reviews Endocrinology 2014
The Association between the LPA Gene Polymorphism and Coronary Artery Disease in Chinese Han Population
ZK Song, HD Wu, HY Cao, L Qin
BioMed Research International 2014
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African–Americans
B Enkhmaa, E Anuurad, W Zhang, L Berglund
Atherosclerosis 2014
Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry: Characterization of apolipoprotein(a) by UPLC/MS
ME Lassman, TM McLaughlin, H Zhou, Y Pan, SM Marcovina, O Laterza, TP Roddy
Rapid communications in mass spectrometry : RCM 2014
Managing Cardiovascular Complications in Diabetes: Betteridge/Managing Cardiovascular Complications in Diabetes
A Lansdown, E Ellins, J Halcox
Managing Cardiovascular Complications in Diabetes: Betteridge/Managing Cardiovascular Complications in Diabetes 2014
Prognostic value of serum lipoprotein(a) levels in patients with acute ischemic stroke:
W Zhang, XA Zhang
NeuroReport 2014
Critical review of non-statin treatments for dyslipoproteinemia
J Pang, DC Chan, GF Watts
Expert Review of Cardiovascular Therapy 2014
New and Emerging Risk Factors for Coronary Heart Disease:
E Akhabue, J Thiboutot, J Cheng, TJ Vittorio, G Christodoulidis, KM Grady, S Lerakis, CE Kosmas
The American Journal of the Medical Sciences 2014
Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype
A Cenarro, J Puzo, J Ferrando, R Mateo-Gallego, AM Bea, P Calmarza, E Jarauta, F Civeira
Metabolism 2014
Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk
A Langsted, PR Kamstrup, BG Nordestgaard
Atherosclerosis 2014
Genetic variants in PLG, LPA, and SIGLEC 14 as well as smoking contribute to plasma plasminogen levels
Q Ma, AB Ozel, S Ramdas, B McGee, R Khoriaty, D Siemieniak, HD Li, Y Guan, LC Brody, JL Mills, AM Molloy, D Ginsburg, JZ Li, KC Desch
Blood 2014
Lipoprotein(a)
ML Koschinsky, MB Boffa
Endocrinology and metabolism clinics of North America 2014
Genetics of coronary heart disease with reference to ApoAI-CIII-AIV gene region
S Agrawal
World journal of cardiology 2014
Evolving targets for lipid-modifying therapy
RQ Do, SJ Nicholls, GG Schwartz
EMBO Molecular Medicine 2014
Low birthweight and elevated levels of lipoprotein(a) in prepubertal children: Low birthweight and lipoprotein(a)
M Rodríguez-Moran, F Guerrero-Romero
J Paediatr Child Health 2014
Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)
R Romagnuolo, SM Marcovina, MB Boffa, ML Koschinsky
Journal of lipid research 2014
Lipoprotein (a): Structure, Pathophysiology and Clinical Implications
RC Maranhão, PO Carvalho, CC Strunz, F Pileggi
Arquivos brasileiros de cardiologia 2014
Relationships of Plasma Lipoprotein(a) Levels with Insulin Resistance in Hypertensive Patients
L Marzano, GL Colussi, MD Torre, LA Sechi, C Catena
Metabolism 2014
Copy number variation of the Lipoprotein(a) (LPA) gene is associated with coronary artery disease in a southern Han Chinese population
Zhijun Wu, Haihui Sheng, Yanjia Chen, Jing Tang, Yan Liu, Qiujing Chen, Lin Lu, Wei Jin
International journal of clinical and experimental medicine 2014
Dyslipidemias in Kidney Disease
A Covic, M Kanbay, EV Lerma
2014
Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator
MB Boffa, ML Koschinsky
Current Atherosclerosis Reports 2013
Lack of association between carotid intima-media thickness and apolipoprotein (a) isoforms in a sample of Spanish general population
P Calmarza, JM Trejo, C Lapresta, P Lopez
Journal of Cardiology 2013
eLS
YC Chang, YH Yu, LM Chuang
Encyclopedia of Life Sciences 2013
When should we measure lipoprotein (a)?
KM Kostner, W Marz, GM Kostner
European Heart Journal 2013
Lipoprotein(a): a promising marker for residual cardiovascular risk assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou
Disease Markers 2013
Screening for and Management of Elevated Lp(a)
MB Boffa, ML Koschinsky
Current Cardiology Reports 2013
The Relationship Between Serum Lipoprotein (a) Levels and Ischemic Stroke Risk: A Cohort Study in the Chinese Population
S Li, Y Gao, W Ma, H Wang, G Zhou, W Guo, Y Liu
Inflammation 2013
Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21483 women
JS Danik, JE Buring, DI Chasman, RY Zee, PM Ridker, RJ Glynn
Journal of Thrombosis and Haemostasis 2013
Lipoprotein(a) plasma levels and the risk of cancer: the PRIME study
É Marrer, A Wagner, M Montaye, G Luc, P Amouyel, J Dallongeville, P Ducimetiere, A Bingham, D Arveiler, M Velten
European Journal of Cancer Prevention 2013
Lipoprotein(a): epidemiology, atherogenic activity and impact on cardiovascular risk
BA Phan, PP Toth
Clinical Lipidology 2013
Lipoprotein(a) metabolism: Potential sites for therapeutic targets
J Hoover-Plow, M Huang
Metabolism 2012
Carotid Intima-Media Thickness in Asymptomatic Subjects With Low Lipoprotein(a) Levels
K Kotani, N Sakane
Journal of clinical medicine research 2012
Lipoprotein(a) and cardiovascular disease in diabetic patients
Q Qi, L Qi
Clinical Lipidology 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Lipid, lipoprotein and apolipoprotein profiles in European adolescents and its associations with gender, biological maturity and body fat—The HELENA Study
A Spinneker, S Egert, M González-Gross, C Breidenassel, U Albers, B Stoffel-Wagner, I Huybrechts, Y Manios, E Venneria, D Molnar, K Widhalm, L Moreno, P Stehle
European Journal of Clinical Nutrition 2012
Lipoprotein(a) : more interesting than ever after 50 years
JB Dubé, MB Boffa, RA Hegele, ML Koschinsky
Current Opinion in Lipidology 2012
Genetics of coronary artery disease: Genome-wide association studies and beyond
BP Prins, V Lagou, FW Asselbergs, H Snieder, J Fu
Atherosclerosis 2012
MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis
F Lu, X Zhao, J Wu, Y Cui, Y Mao, K Chen, Y Yuan, D Gong, Z Xu, S Huang
International Journal of Cardiology 2012
Lipoprotein(a), Ferritin, and Albumin in Acute Phase Reaction Predicts Severity and Mortality of Acute Ischemic Stroke in North Indian Patients
B Chakraborty, G Vishnoi, B Goswami, SH Gowda, D Chowdhury, S Agarwal
Journal of Stroke and Cerebrovascular Diseases 2012
Lipoprotein(a): resurrected by genetics
F Kronenberg, G Utermann
Journal of Internal Medicine 2012
Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study
X Lv, Y Zhang, S Rao, F Liu, X Zuo, D Su, M Wang, M Xia, H Guo, D Feng, C Hong, D Li, W Ma, P Ouyang, X Li, X Feng, Y Yang, W Ling, J Qiu
Lipids in Health and Disease 2012
Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients
L Egaña-Gorroño, E Martínez, T Escribà, M Calvo, JM Gatell, M Arnedo
Frontiers in immunology 2012
High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: results of a cross-sectional epidemiological survey in Gran Canaria, Spain
M Boronat, P Saavedra, N Pérez-Martín, MJ López-Madrazo, C Rodríguez-Pérez, FJ Nóvoa
Cardiovascular Diabetology 2012
HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels
B Enkhmaa, E Anuurad, W Zhang, A Abbuthalha, XD Li, W Dotterweich, RB Pollard, DM Asmuth, L Berglund
Arteriosclerosis, thrombosis, and vascular biology 2012
Dyslipidaemia in rheumatological autoimmune diseases
TE Toms, VF Panoulas, GD Kitas
The open cardiovascular medicine journal 2011
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
The Incremental Value of Lipids and Inflammatory Biomarkers in Determining Residual Cardiovascular Risk
SS Mangalmurti, MH Davidson
Current Atherosclerosis Reports 2011
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
MS Nenseter, HW Lindvig, T Ueland, G Langslet, L Ose, KB Holven, K Retterstøl
Atherosclerosis 2011
Lipoprotein (a): Perspectives from a lipid-referral program
M Rubenfire, D Vodnala, SM Krishnan, RL Bard, EA Jackson, D Giacherio, RD Brook
Journal of Clinical Lipidology 2011
Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft
P Song, JM Seok, WS Kim, YT Lee, DK Kim, GM Kim
Atherosclerosis 2011
Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women
P Wennberg, F Wensley, ED Angelantonio, L Johansson, K Boman, A Rumley, G Lowe, G Hallmans, J Danesh, JH Jansson
Thrombosis Research 2011
Lipoprotein(a) and Family History of Cardiovascular Disease in Children with Familial Dyslipidemias
O Guardamagna, F Abello, G Anfossi, M Pirro
The Journal of Pediatrics 2011
Lipoprotein(a) and the risk of thromboembolism in Thai children
N Sirachainan, C Chaiyong, A Visudtibhan, W Sasanakul, S Osatakul, P Wongwerawattanakoon, P Kadegasem, A Chuansumrit
Thrombosis Research 2011
Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism
M Konerman, K Kulkarni, PP Toth, SR Jones
Journal of Clinical Lipidology 2011
Differential Associations of Serum Amyloid A and Pentraxin-3 with Allele-Specific Lipoprotein(a) Levels in African Americans and Caucasians
B Enkhmaa, E Anuurad, Z Ozturk, W Zhang, TA Pearson, L Berglund
Translational research : the journal of laboratory and clinical medicine 2011
Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
M Uccello, G Malaguarnera, EM Pelligra, A Biondi, F Basile, M Motta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology 2011
A Comparison of Approaches to Control for Confounding Factors by Regression Models
G Xing, CY Lin, C Xing
Human Heredity 2011
Lipoprotein(a): Reloaded
F Kronenberg, G Utermann
Current Cardiovascular Risk Reports 2011
Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14,500 participants of six White European cohorts
D Zabaneh, M Kumari, M Sandhu, N Wareham, N Wainwright, T Papamarkou, J Hopewell, R Clarke, KW Li, J Palmen, PJ Talmud, F Kronenberg, C Lamina, M Summerer, B Paulweber, J Price, G Fowkes, M Stewart, F Drenos, S Shah, T Shah, JP Casas, M Kivimaki, J Whittaker, AD Hingorani, SE Humphries
Atherosclerosis 2011
Lipoprotein(a): Genotype–Phenotype Relationship and Impact on Atherogenic Risk
B Enkhmaa, E Anuurad, W Zhang, T Tran, L Berglund
Metabolic Syndrome and Related Disorders 2011
Sex hormones and lipoprotein(a) concentration
G Gaeta, S Lanero, S Barra, N Silvestri, V Cuomo, C Materazzi, G Vitagliano
Expert Opinion on Investigational Drugs 2011
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
S Lamon-Fava, SM Marcovina, JJ Albers, H Kennedy, C DeLuca, CC White, LA Cupples, JR McNamara, LJ Seman, V Bongard, EJ Schaefer
Journal of lipid research 2011
Single-Nucleotide Polymorphisms in LPA Explain Most of the Ancestry-Specific Variation in Lp(a) Levels in African Americans
RC Deo, JG Wilson, C Xing, K Lawson, WH Kao, D Reich, A Tandon, E Akylbekova, N Patterson, TH Mosley, E Boerwinkle, HA Taylor, JK Pritchard
PloS one 2011
Variation in LPA Is Associated with Lp(a) Levels in Three Populations from the Third National Health and Nutrition Examination Survey
L Dumitrescu, K Glenn, K Brown-Gentry, C Shephard, M Wong, MJ Rieder, JD Smith, DA Nickerson, DC Crawford, A Kloss-Brandstaetter
PloS one 2011
Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk
J Ronald, R Rajagopalan, F Cerrato, AS Nord, T Hatsukami, T Kohler, S Marcovina, P Heagerty, GP Jarvik
Stroke; a journal of cerebral circulation 2011
Estrogen attenuates vascular remodeling in Lp(a) transgenic mice
F Nakagami, H Nakagami, MK Osako, M Iwabayashi, Y Taniyama, T Doi, H Shimizu, M Shimamura, H Rakugi, R Morishita
Atherosclerosis 2010
Association of Lp-PLA2 activity with allele-specific Lp(a) levels in a bi-ethnic population
B Enkhmaa, E Anuurad, W Zhang, TA Pearson, L Berglund
Atherosclerosis 2010
Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus
D Shiffman, JZ Louie, CM Rowland, MJ Malloy, JP Kane, JJ Devlin
Atherosclerosis 2010
Apolipoprotein(a) Isoforms and the Risk of Vascular Disease
S Erqou, A Thompson, ED Angelantonio, D Saleheen, S Kaptoge, S Marcovina, J Danesh
Journal of the American College of Cardiology 2010
Translating genomic analyses into improved management of coronary artery disease
CT Johansen, MB Lanktree, RA Hegele
Future Cardiology 2010
An Elevated Level of Physical Activity Is Associated With Normal Lipoprotein(a) Levels in Individuals From Maracaibo, Venezuela
V Bermúdez, D Aparicio, E Rojas, L Peñaranda, F Finol, L Acosta, E Mengual, J Rojas, N Arráiz, A Toledo, C Colmenares, J Urribarí, W Sanchez, C Pineda, D Rodriguez, J Faria, R Añez, R Cano, C Cano, L Sorell, M Velasco
American Journal of Therapeutics 2010
Leptin is associated with the size of the apolipoprotein(a) particle in African tribal populations living on fish or vegetarian diet
M Winnicki, M Puato, VK Somers, A Zambon, SM Marcovina, M Rattazzi, BG Phillips, P Pauletto
Atherosclerosis 2010
Effects of Ezetimibe on Remnant-Like Particle Cholesterol, Lipoprotein (a), and Oxidized Low-Density Lipoprotein in Patients with Dyslipidemia
T Nozue, I Michishita, I Mizuguchi
Journal of Atherosclerosis and Thrombosis 2010
Management of Lp(a)†
WV Brown, CM Ballantyne, PH Jones, S Marcovina
Journal of Clinical Lipidology 2010
Extremely elevated lipoprotein(a), combined hyperlipidemia, and premature atherosclerosis in a Chinese family
EM deGoma, MT Wheeler, SM Marcovina, EA Ashley
Journal of Clinical Lipidology 2010
The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles
K Arai, MM Luke, ML Koschinsky, ER Miller, CR Pullinger, JL Witztum, JP Kane, S Tsimikas
Atherosclerosis 2010
Formes rares de dyslipidémies génétiques
G Luc
EMC - Endocrinologie - Nutrition 2010
Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet
N Faghihnia, S Tsimikas, ER Miller, JL Witztum, RM Krauss
Journal of lipid research 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Genetic basis of myocardial infarction: Novel insights from genome-wide association studies
J Erdmann, P Linsel-Nitschke, H Schunkert
Current Cardiovascular Risk Reports 2009
Antiphospholipid antibodies and lipoprotein(a) in obese children
D Pascut, T Princi, M Donato, G Tamaro, S Parco
Acta Paediatrica 2009
All-Cause Mortality and Competing Risks of Fatal and Nonfatal Vascular Events in the Italian Longitudinal Study on Aging: Impact of Lipoprotein(a)
V Solfrizzi, AM Colacicco, A D'Introno, C Capurso, M Chirico, V Frisardi, M Cacciapaglia, G Vendemiale, A Capurso, F Panza
Rejuvenation Research 2009
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease
DA Trégouët, IR König, J Erdmann, A Munteanu, PS Braund, AS Hall, A Großhennig, P Linsel-Nitschke, C Perret, M DeSuremain, T Meitinger, BJ Wright, M Preuss, AJ Balmforth, SG Ball, C Meisinger, C Germain, A Evans, D Arveiler, G Luc, JB Ruidavets, C Morrison, P der Harst, S Schreiber, K Neureuther, A Schäfer, P Bugert, NE el Mokhtari, J Schrezenmeir, K Stark, D Rubin, HE Wichmann, C Hengstenberg, W Ouwehand, A Ziegler, L Tiret, JR Thompson, F Cambien, H Schunkert, NJ Samani
Nature Genetics 2009
Lipoprotein a: where are we now?
K Tziomalos, VG Athyros, AS Wierzbicki, DP Mikhailidis
Current Opinion in Cardiology 2009
Lipoprotein(a): a causal independent risk factor for coronary heart disease?
V Gudnason
Current Opinion in Cardiology 2009
Mendelian randomization: nature's randomized trial in the post-genome era
G Thanassoulis, CJ O'Donnell
Journal of the American Medical Association 2009
The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10
K Hirschfeldova, D Lipovska, P Skrha, R Ceska
Clinica Chimica Acta 2009
Designing a study to evaluate the effect of apheresis in patients with elevated lipoprotein(a)
U Kassner, A Vogt, A Rosada, F Barz, E Giannakidou-Jordan, HK Berthold, E Steinhagen-Thiessen
Atherosclerosis Supplements 2009
Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus
F Galvano, GL Volti, M Malaguarnera, T Avitabile, T Antic, M Vacante, M Malaguarnera
Expert Opinion on Pharmacotherapy 2009
Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q
C Ober, AS Nord, EE Thompson, L Pan, Z Tan, D Cusanovich, Y Sun, R Nicolae, C Edelstein, DH Schneider, C Billstrand, D Pfaffinger, N Phillips, RL Anderson, B Philips, R Rajagopalan, TS Hatsukami, MJ Rieder, PJ Heagerty, DA Nickerson, M Abney, S Marcovina, GP Jarvik, AM Scanu, DL Nicolae
Journal of lipid research 2009
Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons
DL Rainwater, LA Cox, J Rogers, JL VandeBerg, MC Mahaney
Journal of lipid research 2009
Population-Based Genomewide Genetic Analysis of Common Clinical Chemistry Analytes
DI Chasman, G Paré, PM Ridker
Clinical chemistry 2009
Handbook on Analyzing Human Genetic Data
S Lin, H Zhao
2009
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease
DA Trégouët, IR König, J Erdmann, A Munteanu, PS Braund, AS Hall, A Großhennig, P Linsel-Nitschke, C Perret, M DeSuremain, T Meitinger, BJ Wright, M Preuss, AJ Balmforth, SG Ball, C Meisinger, C Germain, A Evans, D Arveiler, G Luc, JB Ruidavets, C Morrison, P van der Harst, S Schreiber, K Neureuther, A Schäfer, P Bugert, NE Mokhtari, J Schrezenmeir, K Stark, D Rubin, HE Wichmann, C Hengstenberg, W Ouwehand, A Ziegler, L Tiret, JR Thompson, F Cambien, H Schunkert, NJ Samani
Nature Genetics 2009
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J
Journal of the American Medical Association 2009
The apolipoprotein(a) gene: Linkage disequilibria at three loci differs in African Americans and Caucasians
J Rubin, HJ Kim, TA Pearson, S Holleran, L Berglund, R Ramakrishnan
Atherosclerosis 2008
Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels
S López, A Buil, J Ordoñez, JC Souto, L Almasy, M Lathrop, J Blangero, F Blanco-Vaca, J Fontcuberta, JM Soria
European Journal of Human Genetics 2008
Lipoprotein (a) erhöht das Infarktrisiko
T Hucko, K Graf
Der Kardiologe 2008
Apoprotein(A) Isoforms and Plasma LP(A) Concentration in Members of Four Families
D Labudovik, K Tosheska, S Alabakovska, J Bogdanska, BB Todorova
Journal of Medical Biochemistry 2008
Lipoprotein(a) and coronary artery disease: Ongoing debate
T Celik, C Yuksel, A Iyisoy, E Isik
Nutrition, Metabolism and Cardiovascular Diseases 2008
Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome
A Onat, G Hergenç, H Özhan, Z Kaya, S Bulur, E Ayhan, G Can
Coronary Artery Disease 2008
Aggregation of lipoprotein and inflammatory parameters in families with a history of premature myocardial infarction: the Tallinn Myocardial Infarction Study
K Aasvee, E Kurvinen, J Sundvall, M Jauhiainen, I Tur
Clinical Chemistry and Laboratory Medicine 2008
LPA and PLG sequence variation and kringle IV-2 copy number in two populations
DC Crawford, Z Peng, JF Cheng, D Boffelli, M Ahearn, D Nguyen, T Shaffer, Q Yi, RJ Livingston, MJ Rieder, DA Nickerson
Human Heredity 2008
Lipoprotein(a), homocysteine, and retinal arteriosclerosis
A Ghorbanihaghjo, A Javadzadeh, H Argani, N Nezami, N Rashtchizadeh, M Rafeey, M Rohbaninoubar, B Rahimi-Ardabili
Molecular vision 2008
Relationship between apo(a) length polymorphism and lipoprotein(a) concentration in healthy Ivorian subjects with single or double apo(a) isoforms
A Edjème-Aké, R Garnotel, S Vallée-Polneau, E Anglés-Cano, D Monnet, P Gillery
Clinical Biochemistry 2008
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians
JK Gambhir, H Kaur, KM Prabhu, JD Morrisett, DS Gambhir
Clinical Biochemistry 2008
The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease
M Catalano, A Cortelazzo, Y Yilmaz, E Perilli, G Carzaniga, E Emanuele
Clinica Chimica Acta 2008
Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR
MB Lanktree, C Rajakumar, JH Brunt, ML Koschinsky, PW Connelly, RA Hegele
Journal of lipid research 2008
A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)
D Melzer, JR Perry, D Hernandez, AM Corsi, K Stevens, I Rafferty, F Lauretani, A Murray, JR Gibbs, G Paolisso, S Rafiq, J Simon-Sanchez, H Lango, S Scholz, MN Weedon, S Arepalli, N Rice, N Washecka, A Hurst, A Britton, W Henley, J de Leemput, R Li, AB Newman, G Tranah, T Harris, V Panicker, C Dayan, A Bennett, MI McCarthy, A Ruokonen, MR Jarvelin, J Guralnik, S Bandinelli, TM Frayling, A Singleton, L Ferrucci, VG Cheung
PLoS genetics 2008
Bioinformatics
JM Keith
Bioinformatics 2008
Therapeutic Lipidology
MH Davidson, PP Toth, KC Maki, AM Gotto
2008
FULL TEXT Chapter 1: Introduction
&NA;
European Journal of Cardiovascular Prevention & Rehabilitation 2007
Lipoproteins, Vascular-Related Genetic Factors, and Human Longevity
F Panza, A D'introno, C Capurso, AM Colacicco, D Seripa, A Pilotto, A Santamato, A Capurso, V Solfrizzi
Rejuvenation Research 2007
Heritability estimation of sex-specific effects on human quantitative traits
L Pan, C Ober, M Abney
Genetic Epidemiology 2007
LPA +93C>T and +121G>A polymorphisms detection by electronic microchip technology
E Sticchi, M Lenti, B Giusti, I Sestini, R Abbate, C Fatini
Molecular Genetics and Metabolism 2007
Fish intake and LPA 93C>T polymorphism: Gene-environment interaction in modulating lipoprotein (a) concentrations
F Sofi, C Fatini, E Sticchi, M Lenti, AM Gori, B Giusti, S Fedi, A Casini, R Abbate, GF Gensini
Atherosclerosis 2007
Lipoprotein profile in Arabian type 2 diabetic patients. Relationship to coronary artery diseases
MH Daghash, A Bener, M Zirie, W Dabdoob, AO Al-Hamaq, ZA Al-Arabi
International Journal of Cardiology 2007
Detection of variability in apo(a) gene transcription regulatory sequences using the DGGE method
K Zídková, V Kebrdlová, L Zlatohlávek, R Češka
Clinica Chimica Acta 2007
Increased Serum Lipoprotein(a) Concentrations and Low Molecular Weight Phenotypes of Apolipoprotein(a) Are Associated with Symptomatic Peripheral Arterial Disease
B Dieplinger, A Lingenhel, N Baumgartner, W Poelz, H Dieplinger, M Haltmayer, F Kronenberg, T Mueller
Clinical chemistry 2007
Plasma Lipoprotein(a) Indicates Risk for 4 Distinct Forms of Vascular Disease
GT Jones, AM van Rij, J Cole, MJ Williams, EH Bateman, SM Marcovina, M Deng, SP McCormick
Clinical chemistry 2007
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals
HJ Milionis, TD Filippatos, T Loukas, ET Bairaktari, AD Tselepis, MS Elisaf
Atherosclerosis 2006
Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study
S Barlera, C Specchia, M Farrall, BD Chiodini, MG Franzosi, S Rust, F Green, EB Nicolis, J Peden, G Assmann, R Collins, A Hamsten, G Tognoni, H Watkins
European Journal of Human Genetics 2006
Efficacy and tolerability of combined treatment with l-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus
V Solfrizzi, C Capurso, AM Colacicco, A D’Introno, C Fontana, SA Capurso, F Torres, AM Gadaleta, A Koverech, A Capurso, F Panza
Atherosclerosis 2006
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans
JP Chretien, J Coresh, Y Berthier-Schaad, WH Kao, NE Fink, MJ Klag, SM Marcovina, F Giaculli, MW Smith
Journal of medical genetics 2006
Electroelution of lipoprotein(a) [Lp(a)] from native polyacrylamide gels: A new, simple method to purify Lp(a)
B Chellan, PS Appukuttan, N Jayakumari
Journal of Biochemical and Biophysical Methods 2006
Elevated Lipoprotein(a)—A Genetic Risk Factor for Premature Vascular Disease in People With and Without Standard Risk Factors: A Review
EA Enas, V Chacko, A Senthilkumar, N Puthumana, V Mohan
Disease-a-Month 2006
Ethnicity and lipoprotein(a) polymorphism in Native Mexican populations
G Cardoso-Saldaña, AD la Peña-Díaz, J Zamora-González, R Gomez-Ortega, C Posadas-Romero, R Izaguirre-Avila, E Malvido-Miranda, ME Morales-Anduaga, E Anglés-Cano
Annals of Human Biology 2006
Determinants of risk factors of atherosclerosis in the postinfarction period: The Tallinn MI Study
K Aasvee, M Jauhiainen, E Kurvinen, I Tur, J Sundvall, T Roovere, A Baburin
Scandinavian Journal of Clinical & Laboratory Investigation 2006
Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]
J Rubin, HJ Kim, TA Pearson, S Holleran, R Ramakrishnan, L Berglund
Journal of lipid research 2006
ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study
E Anuurad, G Lu, J Rubin, TA Pearson, L Berglund
Journal of lipid research 2006
Heritable Components of Feline Hematology, Clinical Chemistry, and Acid–Base Profiles
DF Lawler, K Chase, R Teckenbrock, KG Lark
Journal of Heredity 2006
Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein
ML Koschinsky
Current Atherosclerosis Reports 2005
Lipoprotein(a): Implications for clinical practice
RC Block, TA Pearson
Current Atherosclerosis Reports 2005
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes
I Shai, MB Schulze, JE Manson, MJ Stampfer, N Rifai, FB Hu
Diabetologia 2005
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a)
C Catena, M Novello, R Lapenna, S Baroselli, G Colussi, E Nadalini, G Favret, A Cavarape, G Soardo, LA Sechi
Journal of Hypertension 2005
A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study
JA Cooper, GJ Miller, SE Humphries
Atherosclerosis 2005
Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon
K Schmidt, HG Kraft, W Parson, G Utermann
European Journal of Human Genetics 2005
High fidelity screening of regulatory sequences in apolipoprotein(a)-plasminogen cluster
X Lv, HZ Shi, DP Liu, DL Hao, S Zhang, L Xin, XG Li, HM Xu, CC Liang
The International Journal of Biochemistry & Cell Biology 2005
Associations of middle-aged mother's but not father's body mass index with 18-year-old son's waist circumferences, birth weight, and serum hepatic enzyme levels
T Kazumi, A Kawaguchi, G Yoshino
Metabolism 2005
Factors associated with lipoprotein(a) in chronic kidney disease
K Uhlig, SR Wang, GJ Beck, JW Kusek, SM Marcovina, T Greene, AS Levey, MJ Sarnak
American Journal of Kidney Diseases 2005
Conditional Risk Factors for Atherosclerosis
IJ Kullo, CM Ballantyne
Mayo Clinic Proceedings 2005
Serum lipid and apolipoprotein profiles in newborns and six‐year‐old children: The Tallinn Young Family Study
E Kurvinen, K Aasvee, R Zordania, M Jauhiainen, J Sundvall
Scandinavian Journal of Clinical & Laboratory Investigation 2005
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
I Shai, EB Rimm, SE Hankinson, C Cannuscio, G Curhan, JA Manson, N Rifai, MJ Stampfer, J Ma
European Heart Journal 2005
Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels
PT Williams, PJ Blanche, R Rawlings, RM Krauss
The American journal of clinical nutrition 2005
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease
LD Tsironis, CS Katsouras, ES Lourida, JV Mitsios, J Goudevenos, M Elisaf, AD Tselepis
Atherosclerosis 2004
A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a)
W Parson, HG Kraft, H Niederst�tter, AW Lingenhel, S K�chl, F Fresser, G Utermann
Human Mutation 2004
The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients
AC Jansen, ES Aalst-Cohen, MW Tanck, MD Trip, PJ Lansberg, AH Liem, HW van Lennep, EJ Sijbrands, JJ Kastelein
Journal of Internal Medicine 2004
Geriatric depression and vascular diseases: what are the links?
V Camus, H Kraehenbühl, M Preisig, CJ Büla, G Waeber
Journal of Affective Disorders 2004
Convergent evolution in primates and an insectivore
D Boffelli, JF Cheng, EM Rubin
Genomics 2004
GENETICS OF ATHEROSCLEROSIS
AJ Lusis, R Mar, P Pajukanta
Annual Review of Genomics and Human Genetics 2004
Do gene-environment interactions influence fasting plasma lipids? A study of twins
JR Greenfield, K Samaras, AB Jenkins, PJ Kelly, TD Spector, LV Campbell
European Journal of Clinical Investigation 2004
A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription
S Negi, SK Singh, N Pati, V Handa, R Chauhan, U Pati
Biochemical Journal 2004
Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients
M Smaoui, S Hammami, R Chaaba, N Attia, KB Hamda, AS Masmoudi, S Mahjoub, A Bousslama, MB Farhat, M Hammami
Journal of Diabetes and its Complications 2004
El fenotipo de lipoproteína(a): ¿un marcador genético de enfermedad coronaria?
JJ Gómez-Barrado, S Turégano, JC García-Rubira, JM Cruz
Clínica e Investigación en Arteriosclerosis 2004
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation
E Emanuele, E Peros, P Minoretti, A D'Angelo, L Montagna, C Falcone, D Geroldi
Clinica Chimica Acta 2004
Metabolic and nutritional aspects of the atherogenic atypical lipoproteins: Lipoprotein(a), remnant lipoproteins, and oxidized low-density lipoprotein
WJ Castellani
Nutrition Research 2004
Discrepancy of interleukin‐6 levels between end‐stage renal disease patients and patients with acute‐phase response with increased lipoprotein(a) concentrations
KA Yun, W Lee, WK Min, S Chun, YW Lee, SB Kim, JS Park, WS Yang, H Park, SH Hwang
Scandinavian Journal of Clinical & Laboratory Investigation 2004
Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study
K Aasvee, E Kurvinen, R Jordania, M Jauhiainen, J Sundvall
Scandinavian Journal of Clinical & Laboratory Investigation 2004
Meat‐Adaptive Genes and the Evolution of Slower Aging in Humans
CE Finch, CB Stanford
The Quarterly Review of Biology 2004
Genetic and Plasma Markers of Venous Thromboembolism in Patients with High Grade Glioma
FL Sciacca, E Ciusani, A Silvani, E Corsini, S Frigerio, S Pogliani, E Parati, D Croci, A Boiardi, A Salmaggi
Clinical cancer research 2004
Nutrition and Alcohol
R Rylander
Nutrition and Alcohol 2003
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
GD Backer, E Ambrosioni, K Broch-Johnsen, C Brotons, R Cifkova, J Dallongeville, S Ebrahim, O Faergeman, I Graham, G Mancia, VM Cats, K Orth-Gom??r, J Perk, K Py??r??l??, JL Rodicio, S Sans, V Sansoy, U Sechtem, S Silber, T Thomsen, D Wood
European Journal of Cardiovascular Prevention and Rehabilitation 2003
Serum Lipoprotein(a) Concentration and Apo(a) Isoform under The Condition of Renal Dysfunction
M Kuboyama, M Ageta, T Ishihara, Y Fujiura, N Kashio, I Ikushima
Journal of Atherosclerosis and Thrombosis 2003
Serum lipoprotein(a) concentrations and alcohol consumption in hypertension
C Catena, M Novello, L Dotto, SD Marchi, LA Sechi
Journal of Hypertension 2003
Study of Apo(a) Length Polymorphism and Lipoprotein(a) Concentrations in Subjects with Single or Double Apo(a) Isoforms
M Alaoui, C Merle, R Garnotel, D Jolly, V Durlach, P Gillery
Clinical Chemistry and Laboratory Medicine 2003
Sequence and functional changes in a putative enhancer region upstream of the apolipoprotein(a) gene
LH Puckey, BL Knight
Atherosclerosis 2003
Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease
FS Geethanjali, K Luthra, A Lingenhel, AS Kanagasaba-Pathy, J Jacob, LM Srivastava, S Vasisht, HG Kraft, G Utermann
Atherosclerosis 2003
Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle Heart Project
A Tavridou, N Unwin, R Bhopal, MF Laker
European Journal of Clinical Investigation 2003
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
PR de Nolting, JC Defesche, RJ Buirma, BA Hutten, PJ Lansberg, JJ Kastelein
Journal of Internal Medicine 2003
Pentanucleotide TTTTA and G/A –914 DNA Polymorphisms in Apolipoprotein(a) Promoter: Genotyping by Single-Tube PCR
M Živković, A Stanković, D Alavantić
Clinical Chemistry and Laboratory Medicine 2003
Lipoprotein (a) and Apolipoprotein (a) Isoform Size in Thyroid Disease: The Quest for the Golden Fleece
LH Duntas
Thyroid 2003
Lipoprotein (a) Levels and Apolipoprotein (a) Isoform Size in Patients with Subclinical Hypothyroidism: Effect of Treatment with Levothyroxine
HJ Milionis, Z Efstathiadou, AD Tselepis, ET Bairaktari, LD Tsironis, A Tsatsoulis, MS Elisaf
Thyroid 2003
Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents
A Psyrogiannis, I Habeos, V Kyriazopoulou
Lipids in Health and Disease 2003
Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability
D Noto, A Pace, AB Cefalù, CM Barbagallo, M Rizzo, G Marino, G Emmanuele, S Travali, A Notarbartolo, M Averna
Clinica Chimica Acta 2003
Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans
E Emanuele
Neuroscience Letters 2003
Two-locus Linkage Analysis Applied to Putative Quantitative Trait Loci for Lipoprotein(a) Levels
M Beekman, BT Heijmans, NG Martin, JB Whitfield, NL Pedersen, U DeFaire, H Snieder, N Lakenberg, P Knijff, RR Frants, GJ van Ommen, C Kluft, GP Vogler, PE Slagboom, DI Boomsma
Twin Research 2003
Lipoprotein(a): An Emerging Cardiovascular Risk Factor
G Lippi, G Guidi
Critical Reviews in Clinical Laboratory Sciences 2003
Increased plasma adrenomedullin and serum lipoprotein (a) levels in patients with Behcet's disease
I Kocer, A Kiziltunc, S Taysi, A Yildirim
The Pain Clinic 2003
Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation
F Nassir, Y Xie, NO Davidson
Journal of lipid research 2003
Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids
BE Aouizerat, M Kulkarni, D Heilbron, D Drown, S Raskin, CR Pullinger, MJ Malloy, JP Kane
Journal of lipid research 2003
Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation
F Kronenberg, K Lhotta, P König, R Margreiter, H Dieplinger, G Utermann
European Journal of Human Genetics 2003
Subclinical Hypothyroidism and Lipid Abnormalities in Older Women Attending a Vascular Disease Prevention Clinic: Effect of Thyroid Replacement Therapy
ES Ganotakis, K Mandalaki, M Tampakaki, N Malliaraki, E Mandalakis, G Vrentzos, J Melissas, E Castanas
Angiology 2003
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
SM Marcovina, ML Koschinsky, JJ Albers, S Skarlatos
Clinical chemistry 2003
Role of Hypolipidemic Drug Clofibrate in Altering Iron Regulatory Proteins IRP1 and IRP2 Activities and Hepatic Iron Metabolism in Rats Fed a Low-Iron Diet
HL Huang, NS Shaw
Toxicology and Applied Pharmacology 2002
Hormonal influences on lipoprotein(a) metabolism
RW Pang, KS Lam
Diabetes, Obesity and Metabolism 2002
Searching for the mountains of the moon: Genome scans for atherosclerosis
MA Province
Current Atherosclerosis Reports 2002
Lipid profile during rhGH therapy in pediatric renal transplant patients
L Ghio, B Damiani, R Garavaglia, G Oppizzi, E Taioli, A Edefonti
Pediatric Transplantation 2002
Relation of Apolipoprotein (a) Phenotypes to Diabetic Retinopathy in Elderly Type 2 Diabetes
T Suzuki, K Oba, Y Igari, N Matsumura, Y Inuzuka, Y Kigawa, Y Matsuura, Y Ajiro, K Okazaki, H Nakano
Journal of Nippon Medical School 2002
Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk
S Gonbert, S Malinsky, AC Sposito, H Laouenan, C Doucet, MJ Chapman, J Thillet
Atherosclerosis 2002
Growth hormone deficiency and vascular risk
RW McCallum, JR Petrie, AF Dominiczak, JM Connell
Clinical Endocrinology 2002
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly
C Parkinson, WM Drake, G Wieringa, AP Yates, GM Besser, PJ Trainer
Clinical Endocrinology 2002
Radical trapping in glycogen storage disease 1a
B Wittenstein, M Klein, B Finckh, K Ullrich, A Kohlschütter
European Journal of Pediatrics 2002
Lipoprotein(a) as a potent risk indicator for early cardiovascular disease
A Dirisamer, K Widhalm
Acta Paediatrica 2002
Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia
B Wittenstein, M Klein, B Finckh, K Ullrich, A Kohlschütter
Free radical biology & medicine 2002
SERUM LIPOPROTEIN(A) CONCENTRATIONS AND APOLIPOPROTEIN(A) PHENOTYPES IN HEMODIALYSIS, CHRONIC AMBULATORY PERITONEAL DIALYSIS AND POST-TRANSPLANT PATIENTS
E Kimak, J Solski
Renal Failure 2002
Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers
LH Puckey, BL Knight
Biochemical Journal 2002
Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism
C Gazzaruso, A Garzaniti, S Giordanetti, C Falcone, P Fratino
Cardiovascular Diabetology 2002
Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease
V Solfrizzi, F Panza, A D'Introno, AM Colacicco, C Capurso, AM Basile, A Capurso
Journal of neurology, neurosurgery, and psychiatry 2002
Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population
F Paultre, CH Tuck, B Boden-Albala, DE Kargman, E Todd, J Jones, MC Paik, RL Sacco, L Berglund
Arteriosclerosis, thrombosis, and vascular biology 2002
Low birth weight is associated with elevated serum lipoprotein(a) in white and black American children ages 5–11 y
IS Okosun, GE Dever, ST Choi
Public Health 2002
A comprehensive linkage analysis for myocardial infarction and its related risk factors
U Broeckel, C Hengstenberg, B Mayer, S Holmer, LJ Martin, AG Comuzzie, J Blangero, P Nürnberg, A Reis, GA Riegger, HJ Jacob, H Schunkert
Nature Genetics 2002
Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases
M Akaike, H Azuma, A Kagawa, K Matsumoto, I Hayashi, K Tamura, T Nishiuchi, T Iuchi, N Takamori, K Aihara, T Yoshida, Y Kanagawa, T Matsumoto
Clinical chemistry 2002
Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease
S Martín, J Pedro-Botet, J Joven, JM Simó, MG Ladona, M Pavesi, J Rubiés-Prat
Journal of Laboratory and Clinical Medicine 2002
Low birth weight is associated with elevated serum lipoprotein(a) in white and black American children ages 5?11 y
I OKOSUN
Public Health 2002
Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease
U Lundstam, J Herlitz, T Karlsson, T Linden, O Wiklund
Journal of Internal Medicine 2002
Genetic and Environmental Influences on Lipids, Lipoproteins, and Apolipoproteins: Effects of Menopause
RP Middelberg, TD Spector, R Swaminathan, H Snieder
Arteriosclerosis, thrombosis, and vascular biology 2002
Locus Controlling LDL Cholesterol Response to Dietary Cholesterol Is on Baboon Homologue of Human Chromosome 6
CM Kammerer, DL Rainwater, LA Cox, JL Schneider, MC Mahaney, J Rogers, JL VandeBerg
Arteriosclerosis, thrombosis, and vascular biology 2002
Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism
U Nowak-Göttl, R Schobess, K Kurnik, D Schwabe, G Fleischhack, R Junker
Blood 2002
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians
J Rubin, F Paultre, CH Tuck, S Holleran, RG Reed, TA Pearson, CM Thomas, R Ramakrishnan, L Berglund
Journal of lipid research 2002
Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins
Kalpana Luthra, Balram Bharghav, Shivani Chabbra, Nibhriti Das, Anoop Misra, Dharam P Agarwal, Ravindra M Pandey, L M Srivastava
Molecular and Cellular Biochemistry 2002
Potentielle genetische Polymorphismen der venösen Thromboembolie. New Candidate Gene Polymorphisms in Venous Thrombosis
M Depka, S Ehrenforth
LaboratoriumsMedizin 2001
Journal of Cardiovascular Risk
S Kumbasar, I Dincer, F Ertas, S Gulec, C Erol, O Akyurek, M Kilickap, D Oral, E Sipahi, Y Laleli
Journal of Cardiovascular Risk 2001
Monogenic Dyslipidemias: Window on Determinants of Plasma Lipoprotein Metabolism
RA Hegele
The American Journal of Human Genetics 2001
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
C Lahoz, EJ Schaefer, LA Cupples, PW Wilson, D Levy, D Osgood, S Parpos, J Pedro-Botet, JA Daly, JM Ordovas
Atherosclerosis 2001
Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor
J Masuda, T Nabika, Y Notsu
Current Opinion in Neurology 2001
Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia
H Kim, SM Marcovina, KL Edwards, B McKnight, CM Bradley, MJ McNeely, BM Psaty, AG Motulsky, MA Austin
Clinical Genetics 2001
Genetic Evaluation of Lipoprotein(a) in Intracranial Aneurysm Disease
GA Roberts, BT Corcoran, LL Pfouts, JP Phillips, MA Farrell, DJ Bouchier-Hayes, PB Collins
Neurosurgery 2001
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects
C Gazzaruso, A Garzaniti, C Falcone, D Geroldi, G Finardi, P Fratino
Diabetic Medicine 2001
The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)n polymorphism with coronary heart disease
Á Kalina, A Császár, G Füst, B Nagy, C Szalai, I Karádi, J Duba, Z Prohászka, L Horváth, H Dieplinger
Clinica Chimica Acta 2001
The apolipoprotein(a) size, pentanucleotide repeat, C/T(+93) polymorphisms of apolipoprotein(a) gene, serum lipoprotein(a) concentrations and their relationship in a Korean population
JH Kim, KH Roh, SM Nam, HY Park, Y Jang, DK Kim, KS Song
Clinica Chimica Acta 2001
Atherosclerosis and Autoimmunity
EC Lau
Atherosclerosis and Autoimmunity 2001
Kringles of the plasminogen–prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site
M Dominguez, G Rojas, S Loyau, M Bazurco, L Sorell, E Anglés-Cano
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 2001
Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men
M Seed, KL Ayres, SE Humphries, GJ Miller
The American Journal of Medicine 2001
Lipoproteína (a): fisiopatología y consideraciones clínicas y terapéuticas
L Enríquez, P Matas
Medicina Clínica 2001
Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects
L A Sechi, S De Marchi
Journal of Investigative Medicine 2001
Body fat, fat distribution and serum lipids, lipoproteins and apolipoproteins in African-American and Caucasian-American prepubertal children
SL Herd, BA Gower, N Dashti, MI Goran
International Journal of Obesity 2001
Functional Analysis of the Chimpanzee and Human apo(a) Promoter Sequences: IDENTIFICATION OF SEQUENCE VARIATIONS RESPONSIBLE FOR ELEVATED TRANSCRIPTIONAL ACTIVITY IN CHIMPANZEE
T Huby, C Dachet, RM Lawn, J Wickings, MJ Chapman, J Thillet
The Journal of biological chemistry 2001
Genetic linkage methods for quantitative traits
CI Amos, M Andrade
Statistical Methods in Medical Research 2001
Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia: Characterization of a New Plasma Fragment Pattern
S Gonbert, B Saint-Jore, P Giral, C Doucet, J Chapman, J Thillet
Arteriosclerosis, thrombosis, and vascular biology 2001
30th Hemophilia Symposium Hamburg 1999
I Scharrer, W Schramm
2001
Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene
J Rubin, TA Pearson, RG Reed, L Berglund
Clinical chemistry 2001
Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures
J Wang, J Boedeker, HH Hobbs, AL White
Journal of lipid research 2001
Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts
RC Hoogeveen, JK Gambhir, DS Gambhir, KT Kimball, K Ghazzaly, JW Gaubatz, M Vaduganathan, RS Rao, M Koschinsky, JD Morrisett
Journal of lipid research 2001
Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment
Z Tang, R P Tracy
Journal of Thrombosis and Thrombolysis 2001
Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels
M Paassilta, A Karjalainen, K Kervinen, MJ Savolainen, J Heikkinen, AC Bäckström, YA Kesäniemi
Atherosclerosis 2000
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow
Annual Review of Genetics 2000
LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level
O Rosby, K Berg
Journal of Internal Medicine 2000
Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients
LA Sechi, C Catena, D Casaccio, L Zingaro
Journal of Hypertension 2000
Premenopausal Black Women Are Uniquely at Risk for Coronary Heart Disease Compared to White Women
GT Gerhard, G Sexton, MR Malinow, RC Wander, SL Connor, AS Pappu, WE Connor
Preventive Cardiology 2000
Lipoprotein(a): a molecular vignette of an evolving risk factor
E Mohler
ACC Current Journal Review 2000
The effect of apolipoprotein(a)-, apolipoprotein E-, and apolipoprotein A4- polymorphisms on quantitative lipoprotein(a) concentrations
DI Boomsma, P Knijff, A Kaptein, C Labeur, NG Martin, LM Havekes, HM Princen
Twin Research and Human Genetics 2000
Cardiovascular risk markers in hypothalamic amenorrhoea
KK Miller, S Grinspoon, A Klibanski
Clinical Endocrinology 2000
Effects of normalization of GH hypersecretion on lipoprotein(a) and other lipoprotein serum levels in acromegaly
GF Castro, HF Escobar-Morreale, H Ortega, D Gómez-Coronado, JA Barro, C Varela, MA Lasunción
Clinical Endocrinology 2000
Prothrombotic Risk Factors in Children with Spontaneous Venous Thrombosis and Their Asymptomatic Parents
A Kosch, R Junker, K Kurnik, R Schobess, G Günther, HG Koch, U Nowak-Göttl
Thrombosis Research 2000
Relationship Between Lipoprotein(a) Phenotypes and Plaminogen Activator Inhibitor Type 1 in Diabetic Patients
C Hernández, P Chacón, L Garcı́a-Pascual, J Mesa, R Simó
Thrombosis Research 2000
Lipoprotein(a) in homozygous familial hypercholesterolemia
HG Kraft, A Lingenhel, FJ Raal, M Hohenegger, G Utermann
Arteriosclerosis, thrombosis, and vascular biology 2000
Agregación entre hermanos de factores de riesgo cardiovascular: estudio de Cuenca
VM Vizcaíno, RF Gutiérrez, AL Muńoz, FS Aguilar, AM Sánchez, AC Herráiz
Medicina Clínica 2000
Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease
V Mooser, N Helbecque, J Miklossy, SM Marcovina, P Nicod, P Amouyel
Annals of internal medicine 2000
Lipoprotein(a), tobacco use, and risk of coronary heart disease
M Serrano, J Irala, M Palacios
International Journal of Cardiology 2000
Twenty-four hours of insulin infusion does not lower plasma lipoprotein(a) in healthy men
SC Riemens, RP Dullaart
Scandinavian Journal of Clinical & Laboratory Investigation 2000
Lipoprotein (a) and stroke
HJ Milionis
Journal of clinical pathology 2000
The Effect of Fasting in Ramadan on the Values and Interrelations between Biochemical, Coagulation and Hematological Factors
N Sarraf-Zadegan, M Atashi, GA Naderi, AM Baghai, S Asgary, MR Fatehifar, H Samarian, M Zarei
Annals of Saudi medicine 2000
Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns
V Mooser, MM Berger, L Tappy, C Cayeux, SM Marcovina, R Darioli, P Nicod, R Chioléro
Arteriosclerosis, thrombosis, and vascular biology 2000
An application of apo(a) isoforms for the clinical assessment of Lp(a)
S Takayama, Y Yasumuro, J h Kim, M Ishikawa, D Tsujino, S Matsuo, Y Harada, S Sugii
Journal of Clinical Laboratory Analysis 2000
Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]
J Fan, M Challah, H Shimoyamada, M Shiomi, S Marcovina, T Watanabe
Journal of lipid research 2000
Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure
F Kronenberg, E Kuen, E Ritz, R Junker, P König, G Kraatz, K Lhotta, JF Mann, GA Müller, U Neyer, W Riegel, P Riegler, V Schwenger, AV Eckardstein
Journal of the American Society of Nephrology : JASN 2000
A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly
BN Dardik, CD Schwartzkopf, DE Stevens, RE Chatelain
Journal of lipid research 2000
Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study
N F Chu, L Makowski, J B Chang, D J Wang, S H Liou, S M Shieh
European Journal of Epidemiology 2000
Lipoprotein (a) metabolism estimated by nonsteady-state kinetics
KG Parhofer, T Demant, MM Ritter, HC Geiss, M Donner, P Schwandt
Lipids 1999
Lipoprotein(a)
HH Hobbs, AL White
Current Opinion in Lipidology 1999
Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure
LA Sechi, L Zingaro, C Catena, A Perin, SD Marchi, E Bartoli
Kidney International 1999
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age
C Gazzaruso, A Garzaniti, P Buscaglia, G Bonetti, C Falcone, P Fratino, G Finardi, D Geroldi
Journal of the American College of Cardiology 1999
Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux
LB Nielsen
Atherosclerosis 1999
Lipoprotein metabolism during normal pregnancy
P Brizzi, G Tonolo, F Esposito, L Puddu, S Dessole, M Maioli, S Milia
American Journal of Obstetrics and Gynecology 1999
Associations Among Serum Lipoprotein(a) Levels, Apolipoprotein(a) Phenotypes, and Myocardial Infarction in Patients With Extremely Low and High Levels of Serum Lipoprotein(a)
K Saku, B Zhang, R Liu, K Shirai, K Arakawa
Japanese Circulation Journal 1999
Apolipoprotein(a) size polymorphism in young adults with ischemic stroke
J Peynet, JL Beaudeux, F Woimant, F Flourié, V Giraudeaux, E Vicaut, JM Launay
Atherosclerosis 1999
Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up
L Kerschdorfer, P König, U Neyer, C Bösmüller, K Lhotta, M Auinger, M Hohenegger, P Riegler, R Margreiter, G Utermann, H Dieplinger, F Kronenberg
Atherosclerosis 1999
Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians
K Valenti, E Aveynier, S Leauté, F Laporte, AJ Hadjian
Atherosclerosis 1999
Genetic architecture and evolution of the lipoprotein(a) trait
G Utermann
Current Opinion in Lipidology 1999
EFFECTS OF APOLIPOPROTEIN A GENE POLYMORPHISMS ON LIPOPROTEIN (a) CONCENTRATIONS IN JAPANESE
HY Park, T Nabika, Y Notsu, S Kobayashi, J Masuda
Clinical and Experimental Pharmacology and Physiology 1999
Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome
D Noto, CM Barbagallo, AL Cascio, AB Cefalu, G Cavera, R Caldarella, G Marino, S Travali, I Cutaia, S Maringhini, A Notarbartolo, M Averna
Kidney International 1999
Smoking and Lipid Cardiovascular Risk Factors in Vietnamese Refugees in Australia
M Bermingham, K Brock, D Tran, J Yau, H Tran-Dinh
Preventive Medicine 1999
Are risk factors for atherothrombotic disease associated with back pain sickness absence? The Whitehall II Study
H Hemingway, M Shipley, S Stansfeld, H Shannon, J Frank, E Brunner, M Marmot
Journal of epidemiology and community health 1999
Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: Relation to apolipoprotein(a) size polymorphism
M Arnadottir, AL Berg, F Kronenberg, A Lingenhel, T Hugosson, J Hegbrant, P Nilsson-Ehle
Metabolism 1999
Biochemical risk factors and patient's outcome: the case of lipoprotein(a)
G Lippi, G Guidi
Clinica Chimica Acta 1999
Relationship of lipoprotein(a) levels to physical activity and family history of coronary heart disease
S Martín, R Elosua, MI Covas, M Pavesi, J Vila, J Marrugat
American journal of public health 1999
Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: Relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels
JA Barth, RJ Deckelbaum, TJ Starc, S Shea, L Mosca, L Berglund
Journal of Laboratory and Clinical Medicine 1999
Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice
S Frank, A Hrzenjak, K Kostner, W Sattler, GM Kostner
Biochimica et Biophysica Acta 1999
6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a)
J Wang, AL White
The Journal of biological chemistry 1999
Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription
A Kagawa, H Azuma, M Akaike, Y Kanagawa, T Matsumoto
The Journal of biological chemistry 1999
Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure
HJ Milionis, MS Elisaf, A Tselepis, E Bairaktari, SA Karabina, KC Siamopoulos
American Journal of Kidney Diseases 1999
Lipoprotein (a): A controversial risk factor for atherosclerotic heart disease
AP Rocchini
Journal of Laboratory and Clinical Medicine 1999
Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study
L Brazier, L Tiret, G Luc, D Arveiler, J B Ruidavets, A Evans, J Chapman, F Cambien, J Thillet
Atherosclerosis 1999
Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort
A Gaw, G Docherty, E A Brown, I Ford
Atherosclerosis 1999
Lipoprotein(a), apolipoprotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardiovascular risk factors and nationality
K Aasvee, M Jauhiainen, E Kurvinen, R Jordania, J Sundvall, C Ehnholm
Scandinavian Journal of Clinical & Laboratory Investigation 1999
Estrogen Modulation of Apolipoprotein(a) Expression: IDENTIFICATION OF A REGULATORY ELEMENT
D Boffelli, DA Zajchowski, Z Yang, RM Lawn
The Journal of biological chemistry 1999
Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis
Y Asanuma, S Kawai, H Aoshima, J Kaburaki, Y Mizushima
Arthritis & Rheumatism 1999
Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein
K Nilausen, H Meinertz
The American journal of clinical nutrition 1999
Evidence That Multiple Genes Influence Baseline Concentrations and Diet Response of Lp(a) in Baboons
DL Rainwater, CM Kammerer, JL VandeBerg
Arteriosclerosis, thrombosis, and vascular biology 1999
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
D Périard, A Telenti, P Sudre, JJ Cheseaux, P Halfon, MJ Reymond, SM Marcovina, MP Glauser, P Nicod, R Darioli, V Mooser
Circulation 1999
Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood
U Nowak-Göttl, R Junker, M Hartmeier, HG Koch, N Münchow, G Assmann, A von Eckardstein
Circulation 1999
Evaluation of Genetic Risk Factors for Silent Brain Infarction
Y Notsu, T Nabika, HY Park, J Masuda, S Kobayashi
Stroke; a journal of cerebral circulation 1999
Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments
V Mooser, F Tinguely, P Fontana, V Lenain, M Vaglio, P Ruchat, LK von Segesser, SM Marcovina, M Markert, R Darioli, P Nicod
Arteriosclerosis, thrombosis, and vascular biology 1999
Dose-Dependent Inverse Relationship Between Alcohol Consumption and Serum Lp(a) Levels in Black African Males
P Fontana, V Mooser, P Bovet, C Shamlaye, B Burnand, V Lenain, SM Marcovina, W Riesen, R Darioli
Arteriosclerosis, thrombosis, and vascular biology 1999
Dissecting the Genetic Architecture of Lipids, Lipoproteins, and Apolipoproteins: Lessons From Twin Studies
H Snieder, LJ van Doornen, DI Boomsma
Arteriosclerosis, thrombosis, and vascular biology 1999
Fish Intake, Independent of Apo(a) Size, Accounts for Lower Plasma Lipoprotein(a) Levels in Bantu Fishermen of Tanzania: The Lugalawa Study
SM Marcovina, H Kennedy, GB Bon, G Cazzolato, C Galli, E Casiglia, M Puato, P Pauletto
Arteriosclerosis, thrombosis, and vascular biology 1999
Hämostaseologie
G Müller-Berghaus, B Pötzsch
Hämostaseologie 1999
Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway
AL White, B Guerra, J Wang, RE Lanford
Journal of lipid research 1999
No Relationship between Serum Lipoprotein(A) and Albumin Concentrations in Patients with Acute Phase Response
WK Min, S Chun, SH Hwang, H Park
Annals of Clinical Biochemistry 1999
Transgenic mice expressing a human apolipoprotein[a] allele
F Acquati, R Hammer, B Ercoli, V Mooser, R Tao, V Rönicke, A Michalich, G Chiesa, R Taramelli, HH Hobbs, HJ Müller
Journal of lipid research 1999
The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients: A Prospective Follow-Up
F Kronenberg, U Neyer, K Lhotta, EV Trenkwalder, M Auinger, A Pribasnig, T Meisl, P König, H Dieplinger
Journal of the American Society of Nephrology : JASN 1999
Glycated Hemoglobin Levels and Their Correlation With Atherosclerotic Risk Factors in a Japanese Population
K Kayaba, N Nago, T Miyamoto, M Mizooka, M Terada, K Kario, Y Nakamura, M lgarashi
Japanese Circulation Journal 1998
LP(a) phenotypes and levels in angiographically proven coronary heart disease patients and controls
K Luthra, S Vasisht, S Chhabra, KR Raju, DP Agarwal, SC Manchanda, LM Srivastava
Indian Journal of Clinical Biochemistry 1998
Job strain and biological coronary risk factors: A cross-sectional study of male and female workers in a japanese rural district
A Tsutsumi, K Tsutsumi, K Kayaba, T Theorell, N Nago, K Kario, M Igarashi
International Journal of Behavioral Medicine 1998
Pipoprotein Lp(a): Effects of allelic variation at theLPA locus
DL Rainwater, CM Kammerer
The Journal of Experimental Zoology 1998
Long-Term Variability of Serum Lipoprotein(a) Concentrations in Healthy Fertile Women
R Garnotel, F Monier, F Lefèvre, P Gillery
Clinical Chemistry and Laboratory Medicine 1998
Standardization and Clinical Management of Lipoprotein(a) Measurements
G Lippi, G Guidi
Clinical Chemistry and Laboratory Medicine 1998
Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study
DE Kargman, C Tuck, L Berglund, IF Lin, RS Mukherjee, EV Thompson, J Jones, B Boden-Albala, MC Paik, RL Sacco
Atherosclerosis 1998
Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response
G Lippi, V Braga, S Adami, G Guidi
Clinica Chimica Acta 1998
LIPOPROTEINS AND ATHEROGENESIS
JM Hoeg
Endocrinology & Metabolism Clinics of North America 1998
Oestrogen replacement therapy and coronary heart disease
MR Taskinen
Annals of Medicine 1998
UPDATE ON GENETIC RISK FACTORS FOR THROMBOSIS AND ATHEROSCLEROTIC VASCULAR DISEASE
EJ Neufeld
Hematology/Oncology Clinics of North America 1998
No Effect of Fibrates on Synthesis of Apolipoprotein(a) in Primary Cultures of Cynomolgus Monkey and Human Hepatocytes: Apolipoprotein A-I Synthesis Increased
DM Neele, A Kaptein, H Huisman, EC de Wit, HM Princen
Biochemical and Biophysical Research Communications 1998
Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS–agarose immunoblotting
S Martı́n, MG Ladona, J Pedro-Botet, MI Covas, J Rubiés-Prat
Clinica Chimica Acta 1998
Plasma Lipoprotein(a) Levels Are High in Patients with Central Retinal Artery Occlusion
M Murata, T Saito, S Takahashi, A Ichinose
Thrombosis Research 1998
Genetics of stroke—a review
D Rastenyt≐, J Tuomilehto, C Sarti
Journal of the Neurological Sciences 1998
Premenopausal black women have more risk factors for coronary heart disease than white women
GT Gerhard, G Sexton, MR Malinow, RC Wander, SL Connor, AS Pappu, WE Connor
The American Journal of Cardiology 1998
Atherothrombogenicity of lipoprotein(a): the debate
AM Scanu
The American Journal of Cardiology 1998
Lipoprotein(a) as a risk factor for coronary artery disease
SM Marcovina, ML Koschinsky
The American Journal of Cardiology 1998
Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity
C Gazzaruso, D Geroldi, A Garzaniti, C Falcone, P Fratino, G Finardi, P Buscaglia
International Journal of Cardiology 1998
Influence de l'exercice physique sur la concentration plasmatique de lipoprotéine(a) chez de jeunes athlètes
S Clavel, S Léauté, P Jouanel
Science & Sports 1998
Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect
A Gaw, E A Brown, I Ford
Arteriosclerosis, thrombosis, and vascular biology 1998
Interactions among Lp(a) phenotypes, Lp(a) concentrations and lipoprotein response to fat-modified diets
YH Tsai, S Park, JT Snook
The Journal of Nutritional Biochemistry 1998
Apolipoprotein(a) Gene Enhancer Resides within a LINE Element
Z Yang, D Boffelli, N Boonmark, K Schwartz, R Lawn
The Journal of biological chemistry 1998
Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion
F Nassir, DK Bonen, NO Davidson
The Journal of biological chemistry 1998
The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States
Dahlen, Srinivasan, Srinivasan, Stenlund, Wattigney, Wall, Berenson
Journal of Internal Medicine 1998
Insulin and 2-Hour Glucose Levels Are Inversely Related to Lp(a) Concentrations Controlled for LPA Genotype
DL Rainwater, SM Haffner
Arteriosclerosis, thrombosis, and vascular biology 1998
Alcohol Withdrawal–Induced Change in Lipoprotein(a): Association With the Growth Hormone/Insulin-like Growth Factor-I (IGF-I)/IGF-Binding Protein-1 (IGFBP-1) Axis
M Paassilta, K Kervinen, M Linnaluoto, YA Kesäniemi
Arteriosclerosis, thrombosis, and vascular biology 1998
Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment
RL Wilensky
1998
Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro
DK Bonen, F Nassir, AM Hausman, NO Davidson
Journal of lipid research 1998
Molecular basis of an apolipoprotein[a] null allele: a splice sitemutation is associated with deletion of a single exon
LA Cox, C Jett, JE Hixson
Journal of lipid research 1998
Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region
K Suzuki, M Kuriyama, T Saito, A Ichinose
Journal of Clinical Investigation 1997
Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB
YY van der Hoek, A Lingenhel, HG Kraft, JC Defesche, JJ Kastelein, G Utermann
Journal of Clinical Investigation 1997
The Apo(a) Gene is the Major Determinant of Variation in Plasma Lp(a) Levels in African Americans
V Mooser, D Scheer, SM Marcovina, J Wang, R Guerra, J Cohen, HH Hobbs
The American Journal of Human Genetics 1997
Biogenesis of Lp(a) in transgenic mouse hepatocytes
AL White
Clinical Genetics 1997
Metabolism of Lp(a): assembly and excretion
GM Kostner, X Wo, S Frank, K Kostner, R Zimmermann, E Steyrer
Clinical Genetics 1997
Apolipoproteins and lipoprotein particles in moroccan patients with previous myocardial infarction
A Adlouni, ME Messal, N Ghalim, R SaÏle
International Journal of Clinical & Laboratory Research 1997
Lipoprotein (a) Concentrations in Patients with Various Dyslipidaemias
MS Elisaf, ET Bairaktari, CS Tzallas, KC Siamopoulos
Annals of Medicine 1997
High-degree sequence conservation in LPA kringle IV-type 2 exons and introns
O Rösby, P Aleström, K Berg
Clinical Genetics 1997
Lipoprotein(a): structural implications for pathophysiology
ML Koschinsky, SM Marcovina
International Journal of Clinical & Laboratory Research 1997
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension
C Gazzaruso, P Buscaglia, A Garzaniti, C Falcone, S Mariotti, S Savino, G Bonetti, G Finardi, D Geroldi
Journal of Hypertension 1997
Serum distribution of lipoprotein(a) in African Americans and Nigerians: Potential evidence for a genotype-environmental effect
CN Rotimi, RS Cooper, SM Marcovina, D McGee, E Owoaje, M Ladipo
Genetic Epidemiology 1997
Liprotein(a) Phenotypes in Japanese Children: A Cohort Study
O Arisaka, S Fujiwara, N Miyake, H Mokuno, K Yabuta
Journal of Pediatric Gastroenterology & Nutrition 1997
Opposing Effects of Growth Hormone and Insulin-like Growth Factor I on Serum Lipoprotein(a)
Z Laron, B Klinger, A Silbergeld, XL Wang
Journal of Pediatric Endocrinology and Metabolism 1997
Is it time to measure Lp(a) as part of coronary heart disease risk assessment?
R Hegele
Clinical Biochemistry 1997
Tracking of Serum Lipoprotein (a) Concentration and Its Contribution to Serum Cholesterol Values in Children from 7 to 36 Months of Age in the STRIP Baby Study
T Routi, T Rönnemaa, JS Viikari, A Leino, LA Välimaki, OG Simell
Annals of Medicine 1997
High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay
V Mooser, SM Marcovina, J Wang, HH Hobbs
Clinical Genetics 1997
LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients
F Kronenberg, E Trenkwalder, W Sturm, H Kathrein, P König, U Neyer, E Gröchenig, G Utermann, H Dieplinger
Clinical Genetics 1997
Lipoprotein (a) and the kidney
BG MURPHY
Nephrology 1997
Reporter gene analysis of four DNasel hypersensitive sites in the plasminogen/apolipoprotein(a) intergenic region
F Acquati, V Rönicke, R Taramelli, HJ Müller
Clinical Genetics 1997
The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins
H Snieder, LJ van Doornen, DI Boomsma
The American Journal of Human Genetics 1997
LIPOPROTEIN(a) CONCENTRATION AND MOLECULAR WEIGHT OF APOLIPOPROTEIN(a) IN PATIENTS WITH CEREBROVASCULAR DISEASE AND DIABETES MELLITUS
T Saito, R Ookubo, M Kuriyama, R Sano, A Ichinose
Thrombosis Research 1997
Lipoprotein (a) distribution in a Nigerian population
RW Evans, CH Bunker, FA Ukoli, LH Kuller
Ethnicity and Health 1997
Genomic structure and organisation of kringles type 3 to 10 of the apolipoprotein(a) gene in 6q26–27
A Mihalich, P Magnaghi, L Sessa, M Trubia, F Acquati, R Taramelli
Gene 1997
Monthly intra-individual variation in lipoprotein(a) in 22 normal subjects over 12 months
DJ Nazir, MJ McQueen
Clinical Biochemistry 1997
Small genetic effects in complex diseases: A review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis
RA Hegele
Clinical Biochemistry 1997
Comparative Analysis of Apo(A) Gene Alleles: Distribution of Pentanucleotide Repeats in Position −1373 and C/T Transition in Position +93 among Patients with Myocardial Infarction and a Control Group in St. Petersburg, Russia
MV Volkova, VI Vasina, EV Fomicheva, EI Schwartz
Biochemical and Molecular Medicine 1997
Pentaerythritol tetranicotinate (niceritrol) decreases plasma lipoprotein(a) levels
K Tanaka, K Hayashi, T Shingu, Y Kuga, Y Okura, Y Yasunobu, H Ohtani, S Nomura, H Kurushima, M Saeki, M Kambe, G Kajiyama
Metabolism 1997
Serum LP(a) levels in African Aboriginal Pygmies and Bantus, Compared with Caucasian and Asian Population samples
C Cobbaert, P Mulder, J Lindemans, H Kesteloot
Journal of Clinical Epidemiology 1997
Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease: Rapid Communication
E Trenkwalder, A Gruber, P König, H Dieplinger, F Kronenberg
Kidney International 1997
Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a)
DL Rainwater, CM Kammerer, JL VandeBerg, JE Hixson
Atherosclerosis 1997
Influence of Allelic Variation on Apolipoprotein(a) Folding in the Endoplasmic Reticulum
AL White, B Guerra, RE Lanford
The Journal of biological chemistry 1997
Urinary apo(a) discriminates coronary artery disease patients from controls
KM Kostner, K Huber, T Stefenelli, H Rinner, G Maurer
Atherosclerosis 1997
Characterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene
DP Wade, LH Puckey, BL Knight, F Acquati, A Mihalich, R Taramelli
The Journal of biological chemistry 1997
Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a)
MM Ritter, J Gewitsch, WO Richter, HC Geiss, MW Wildner, P Schwandt
Atherosclerosis 1997
Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells: EVIDENCE FOR INTRACELLULAR ASSEMBLY OF LIPOPROTEIN(a)
DK Bonen, AM Hausman, C Hadjiagapiou, SF Skarosi, NO Davidson
The Journal of biological chemistry 1997
Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
E Anglés-Cano
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] 1997
A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants
SH Wild, SP Fortmann, SM Marcovina
Arteriosclerosis, thrombosis, and vascular biology 1997
Effects of Estrus Cycle, Ovariectomy, and Treatment with Estrogen, Tamoxifen, and Progesterone on Apolipoprotein(a) Gene Expression in Transgenic Mice
BR Zysow, K Kauser, RM Lawn, GM Rubanyi
Arteriosclerosis, thrombosis, and vascular biology 1997
Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women
CH Tuck, S Holleran, L Berglund
Arteriosclerosis, thrombosis, and vascular biology 1997
Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration
RA Hegele, WC Breckenridge, JH Brunt, PW Connelly
Arteriosclerosis, thrombosis, and vascular biology 1997
Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
PN Hopkins, LL Wu, SC Hunt, BC James, GM Vincent, RR Williams
Arteriosclerosis, thrombosis, and vascular biology 1997
Identification of Apo(a) Phenotypes in a Korean Population Using a Standardized Nomenclature System Based on the Number of Kringle IV Repeats
WK Min, JO Lee, CH Kim, J Song, JQ Kim
Annals of Clinical Biochemistry 1997
Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders
YY van der Hoek, RJ Wanders, AE van den Ende, HG Kraft, BR Gabel, JJ Kastelein, ML Koschinsky
Journal of lipid research 1997
Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22
DA Wu, X Bu, CH Warden, DD Shen, CY Jeng, WH Sheu, MM Fuh, T Katsuya, VJ Dzau, GM Reaven, AJ Lusis, JI Rotter, YD Chen
Journal of Clinical Investigation 1996
Lp(a) concentrations are related to plasma lipid concentrations
DL Rainwater
Atherosclerosis 1996
Lipoprotein(a) in renal disease
F Kronenberg, G Utermann, H Dieplinger
American Journal of Kidney Diseases 1996
Lipoprotein(a) is increased in triglyceride-rich lipoproteins in men with coronary heart disease, but does not change acutely following oral fat ingestion
F Hoppichler, HG Kraft, C Sandholzer, M Lechleitner, JR Patsch, G Utermann
Atherosclerosis 1996
The effect of labor force participation on coronary heart disease risk factors among middle-aged women: A cross-sectional study in a Japanese rural district
K Tsutsumi, A Tsutsumi, K Orth-Gomér
International Journal of Behavioral Medicine 1996
Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease
H Amemiya, T Arinami, S Kikuchi, K Yamakawa-Kobayashi, L Li, H Fujiwara, M Hiroe, F Marumo, H Hamaguchi
Atherosclerosis 1996
Interrelationship of triglyceride-rich lipoproteins, serum lipoprotein(a) concentration and apolipoprotein(a) size
M SentÍ, J Pedro-Botet, J Rubiés-Prat, J Marrugat
Scandinavian Journal of Clinical & Laboratory Investigation 1996
The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes
HG Kraft, A Lingenhel, G Bader, GM Kostner, G Utermann
Atherosclerosis 1996
N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels
O Wiklund, G Fager, A Andersson, U Lundstam, P Masson, B Hultberg
Atherosclerosis 1996
Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level
SM Marcovina, G Lippi, CJ Bagatell, WJ Bremner
Atherosclerosis 1996
Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in normoglycaemic relatives of Type 2 diabetic patients
MW Stewart, JM Webster, D Humphriss, T Berrish, M Walker, MF Laker
Atherosclerosis 1996
Treatment with growth hormone increases lipoprotein(a) serum levels in children with chronic renal insufficiency
U Querfeld, D Haffner, E Wühl, AM Wingen, K Wolter, B Friedrich, DV Michalk, O Mehls
European Journal of Pediatrics 1996
Lipoprotein(a) is not elevated in non-diabetic microalbuminuric subjects
JS Yudkin, SM Marcovina, WJ Foyle, M Fernandez
International Journal of Clinical & Laboratory Research 1996
Correlation of toddlers' serum lipoprotein(a) concentration with parental values and grandparents' coronary heart disease: the STRIP baby study
T Routi, T Rönnemaa, E Jokinen, J Viikari, H Niinikoski, A Leino, O Simell
Acta Paediatrica 1996
Molecular genetics as the route to understanding, prevention, and treatment
A Hamsten
The Lancet 1996
Serum lipoprotein(a) [Lp(a)] in alcoholic men: Effect of withdrawal
J Delarue, M Husson, F Schellenberg, J Tichet, S Vol, C Couet, F Lamisse
Alcohol 1996
Racial Variation of Cord Plasma Lipoprotein(a) Levels in Relation to Coronary Risk Level: A Study in Three Ethnic Groups in Singapore
PS Low, CK Heng, N Saha, JS Tay
Pediatric Research 1996
Urinary excretion of testosterone and estradiol in chinese men and relationships with serum lipoprotein concentrations
LS Ooi, NS Panesar, JR Masarei
Metabolism 1996
Lipoprotein(a) in Health and Disease
F Kronenberg, A Steinmetz, GM Kostner, H Dieplinger
Critical Reviews in Clinical Laboratory Sciences 1996
Mixture distributions in human genetics research
NJ Schork, DB Allison, B Thiel
Statistical Methods in Medical Research 1996
The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells
C Brunner, EM Lobentanz, A Pethö-Schramm, A Ernst, C Kang, H Dieplinger, HJ Müller, G Utermann
The Journal of biological chemistry 1996
Effect of a single session of exercise on lipoprotein(a):
JL Durstine, MA Ferguson, LM Szymanski, PG DAVIS, NL Alderson, SG Trost, RR Pate
Medicine and Science in Sports and Exercise 1996
Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect
R Carmena, S Lussier-Cacan, M Roy, A Minnich, A Lingenhel, F Kronenberg, J Davignon
Arteriosclerosis, thrombosis, and vascular biology 1996
Plasma Lipoprotein(a) Levels in Subjects Attending a Metabolic Ward: Discrimination Between Individuals With and Without a History of Ischemic Stroke
M Margaglione, G DiMinno, E Grandone, E Celentano, G Vecchione, G Cappucci, M Grilli, FP Mancini, A Postiglione, S Panico, M Mancini
Arteriosclerosis, thrombosis, and vascular biology 1996
Lipoprotein(a) in Patients With Acute Cerebral Ischemia
F van Kooten, J van Krimpen, DW Dippel, N Hoogerbrugge, PJ Koudstaal
Stroke; a journal of cerebral circulation 1996
Hormone Replacement Therapy Lowers Plasma Lp(a) Concentrations: Comparison of Cyclic Transdermal and Continuous Estrogen-Progestin Regimens
MR Taskinen, J Puolakka, T Pyörälä, H Luotola, M Björn, J Kääriäinen, S Lahdenperä, C Ehnholm
Arteriosclerosis, thrombosis, and vascular biology 1996
Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease
HG Kraft, A Lingenhel, S Köchl, F Hoppichler, F Kronenberg, A Abe, V Mühlberger, D Schönitzer, G Utermann
Arteriosclerosis, thrombosis, and vascular biology 1996
Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women: The Framingham Offspring Study
S Lamon-Fava, PW Wilson, EJ Schaefer
Arteriosclerosis, thrombosis, and vascular biology 1996
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson
1996
Triggering of Acute Coronary Syndromes
SN Willich, JE Muller
1996
Neomycin inhibits secretion of apolipoprotein[a] by increasing retention on the hepatocyte cell surface
RE Lanford, L Estlack, AL White
Journal of lipid research 1996
Identification of promoter sequences in the 5' untranslated region of the baboon apolipoprotein[a] gene
JE Hixson, C Jett, S Birnbaum
Journal of lipid research 1996
Treatment with growth hormone increases lipoprotein(a) serum levels in children with chronic renal insufficiency
U Querfeld, D Haffner, E Wühl, , K Wolter, B Friedrich, DV Michalk, O Mehls
European Journal of Pediatrics 1996
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans
DJ Rader, WA Mann, W Cain, HG Kraft, D Usher, LA Zech, JM Hoeg, J Davignon, P Lupien, M Grossman
Journal of Clinical Investigation 1995
A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians
M Trommsdorff, S Köchl, A Lingenhel, F Kronenberg, R Delport, H Vermaak, L Lemming, IC Klausen, O Faergeman, G Utermann
Journal of Clinical Investigation 1995
Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)
MJ Callow, J Verstuyft, R Tangirala, W Palinski, EM Rubin
Journal of Clinical Investigation 1995
Lipoprotein (a) in patients with hyperlipidaemia
W Bartens, DJ Rader, G Talley, HB Brewer
European Journal of Clinical Investigation 1995
Kringle-dependent structural and functional polymorphism of apolipoprotein (a)
A Scanu
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1995
Genetic basis for multimodal relationship between apolipoprotein (a) size and lipoprotein (a) concentration in Mexican-Americans
DL Rainwater
Atherosclerosis 1995
Further characterization of the plasma lipoprotein(a) distribution
W Craig, S Poulin, A Bostom, C Eaton, J Laurino, T Ledue, R Ritchie
Journal of Clinical Laboratory Analysis 1995
Potential environmental effects on adult lipoprotein(a) levels: results from Swedish twins
Y Hong, GH Dahlén, N Pedersen, DA Heller, GE McClearn, U Faire
Atherosclerosis 1995
The apolipoprotein(a) gene is regulated by sex hormones and acute–phase inducers in YAC transgenic mice
KA Frazer, G Narla, JL Zhang, EM Rubin
Nature Genetics 1995
Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men
J Oscarsson, U Lundstam, BJ Gustafsson, P Wilton, S Edén, O Wlklund
Clinical Endocrinology 1995
Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American Black women
MI Kamboh, RW Evans, CE Aston
Atherosclerosis 1995
High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism
A Császár, I Karádi, E Juhász, L Romics
European Journal of Clinical Investigation 1995
Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease
HK Jensen, PS Hansen, LG Jensen, MJ Kristensen, IC Klausen, M Kjeldsen, L Lemming, L Bolund, N Gregersen, O Faergeman
Clinical Genetics 1995
Elevated Levels of Lipoprotein (a) in Association with Cerebrovascular Saccular Aneurysmal Disease
C Bolger, J Phillips, S Gilligan, T Zourob, M Farrell, D Croake, P Collins, D Bouchier-Hayes
Neurosurgery 1995
Malignant coronary artery disease in young asian indians: Thoughts on pathogenesis, prevention, and therapy
EA Enas, J Mehta
Clinical Cardiology 1995
Lipoprotein (a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica
S Wållberg-Jonsson, A Uddhammar, G Dahlén, S Rantapää-Dahlqvist
Scandinavian Journal of Clinical & Laboratory Investigation 1995
Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus
CA DeMeester, X Bu, RJ Gray, AJ Lusis, JI Rotter
The American Journal of Human Genetics 1995
Method-dependent increase in lipoprotein(a) in insulin-dependent diabetes mellitus during pregnancy
HL Pekelharing, NL Aalders, GH Visser, JJ van Doormaal, BN Bouma, HA Kleinveld, HJ van Rijn
Metabolism 1995
Lipoprotein (a)
PN Durrington
Baillière's Clinical Endocrinology and Metabolism 1995
Whether, to what degree, and why lipoprotein(a) levels change over time
CJ Glueck, T Tracy, L Sieve-Smith, P Wang
Clinica Chimica Acta 1995
An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk
PM Ridker
Trends in Cardiovascular Medicine 1995
Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women
G Tonolo, M Ciccarese, P Brizzi, S Milia, S Dessole, L Puddu, G Secchi, M Maioli
American journal of physiology. Endocrinology and metabolism 1995
Elevated Levels of Lipoprotein (a) in Association with Cerebrovascular Saccular Aneurysmal Disease:
C Bolger, J Phillips, S Gilligan, T Zourob, M Farrell, D Croake, P Collins, D Bouchier-Hayes
Neurosurgery 1995
C/T Polymorphism in the 5′ Untranslated Region of the Apolipoprotein(a) Gene Introduces an Upstream ATG and Reduces In Vitro Translation
BR Zysow, GE Lindahl, DP Wade, BL Knight, RM Lawn
Arteriosclerosis, thrombosis, and vascular biology 1995
Familial Hypobetalipoproteinemia Is Not Associated With Low Levels of Lipoprotein(a)
M Averna, SM Marcovina, D Noto, TG Cole, ES Krul, G Schonfeld
Arteriosclerosis, thrombosis, and vascular biology 1995
Lipid and Lipoprotein Factors Associated With Variation in Lp(a) Density
DL Rainwater, MJ Ludwig, SM Haffner, JL VandeBerg
Arteriosclerosis, thrombosis, and vascular biology 1995
Genetic Basis of Lipoprotein Disorders
M Dammerman, JL Breslow
Circulation 1995
No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans
DJ Moliterno, EV Jokinen, AR Miserez, RA Lange, JE Willard, E Boerwinkle, LD Hillis, HH Hobbs
Arteriosclerosis, thrombosis, and vascular biology 1995
Hormonal Regulation of Serum Lipoprotein(a) Levels: Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor–I
H Olivecrona, AG Johansson, E Lindh, S Ljunghall, L Berglund, B Angelin
Arteriosclerosis, thrombosis, and vascular biology 1995
Effects of Alcohol Consumption on Lipoproteins of Premenopausal Women: A Controlled Diet Study
BA Clevidence, ME Reichman, JT Judd, RA Muesing, A Schatzkin, EJ Schaefer, Z Li, J Jenner, CC Brown, M Sunkin, WS Campbell, PR Taylor
Arteriosclerosis, thrombosis, and vascular biology 1995
Lipoprotein(a) and Asymptomatic Carotid Artery Disease: Evidence of a Prominent Role in the Evolution of Advanced Carotid Plaques: The Bruneck Study
J Willeit, S Kiechl, P Santer, F Oberhollenzer, G Egger, E Jarosch, A Mair
Stroke; a journal of cerebral circulation 1995
Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients
K Hirata, K Saku, S Jimi, S Kikuchi, H Hamaguchi, K Arakawa
Diabetologia 1995
Nutrition and Biotechnology in Heart Disease and Cancer
JB Longenecker, D Kritchevsky, MK Drezner
1995
Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein and liver apolipoprotein[a] mRNA levels
R Ramharack, MA Spahr, GW Hicks, KA Kieft, DW Brammer, LL Minton, RS Newton
Journal of lipid research 1995
Ten allelic apolipoprotein[a] 5' flanking fragments exhibit comparable promoter activities in HepG2 cells
S Bopp, S Köchl, F Acquati, P Magnaghi, A Pethö-Schramm, HG Kraft, G Utermann, HJ Müller, R Taramelli
Journal of lipid research 1995
Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism
HG Kraft, C Haibach, A Lingenhel, C Brunner, M Trommsdorff, F Kronenberg, HJ Mller, G Utermann
Human Genetics 1995
Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles
YF Perombelon, AK Soutar, BL Knight
Journal of Clinical Investigation 1994
Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus
A Gaw, E Boerwinkle, JC Cohen, HH Hobbs
Journal of Clinical Investigation 1994
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate
DJ Rader, W Cain, K Ikewaki, G Talley, LA Zech, D Usher, HB Brewer
Journal of Clinical Investigation 1994
The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma
E Steyrer, S Durovic, S Frank, W Giessauf, A Burger, H Dieplinger, R Zechner, GM Kostner
Journal of Clinical Investigation 1994
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
JC Cohen, Z Wang, SM Grundy, MR Stoesz, R Guerra
Journal of Clinical Investigation 1994
Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis
WL Gregory, FL Game, M Farrer, JR Idle, MF Laker, OF James
Atherosclerosis 1994
Studies on the structure and function of the apolipoprotein(a) gene
CD Byrne, RM Lawn
Clinical Genetics 1994
Lipoprotein(a) in Type 1 Diabetic Patients with Renal Disease
PH Groop, GC Viberti, TG Elliott, R Friedman, A Mackie, C Ehnholm, M Jauhiainen, MR Taskinen
Diabetic Medicine 1994
Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia
G Feussner, V Feussner, R Ziegler
Journal of Internal Medicine 1994
Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia
W Bartens, DJ Rader, G Talley, HB Brewer
Atherosclerosis 1994
Lp(a) lipoprotein in cardiovascular disease
GH Dahlén
Atherosclerosis 1994
Apo(a) Expression in Transgenic Micea
HH Hobbs, G Chiesa, A Gaw, R Lawn, SD Maika, M Koschinsky, R Hammer
Annals of the New York Academy of Sciences 1994
Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia
MM Ritter, HC Geiss, WO Richter, P Schwandt
Metabolism 1994
Serum lipoprotein(a) level is increased in patients with systemic lupus erythematosus irrespective of positivity of antiphospholipid antibodies
J Matsuda, M Gotoh, K Gohchi, N Saitoh, M Tsukamoto
Thrombosis Research 1994
The relationship between infant and parent Lp(a) levels
DE Wilcken, XL Wang, NP Dudman
Chemistry and Physics of Lipids 1994
The apolipoprotein(a) gene: characterization of 5′ flanking regions and expression in transgenic mice
RM Lawn
Chemistry and Physics of Lipids 1994
Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus
SM Haffner, M Frangos, J Williamson, J Santiago, R Valdez, G Aldrete, L Mykkänen, KK Gruber, DL Rainwater
Chemistry and Physics of Lipids 1994
Lipoprotein(a) and coronary heart disease
CR Rodriguez, LJ Seman, JM Ordovas, J Jenner, MS Genest, PW Wilson, EJ Schaefer
Chemistry and Physics of Lipids 1994
Hypervariable polymorphism of APO(a) in blacks and whites as reflected by phenotyping
MI Kamboh, CM Svitko, ER Williams, RE Ferrell, WS Pollitzer
Chemistry and Physics of Lipids 1994
Hormonal agents used in lowering lipoprotein(a)
MR Soma, M Meschia, F Bruschi, JD Morrisett, R Paoletti, R Fumagalli, PG Crosignani
Chemistry and Physics of Lipids 1994
Intracellular processing of apo(a) in primary baboon hepatocytes
AL White, DL Rainwater, JE Hixson, LE Estlack, RE Lanford
Chemistry and Physics of Lipids 1994
Structure and Possible biological roles of Lp(a)
I Karmansky, N Gruener
Clinical Biochemistry 1994
High allele frequency of apolipoprotein(a) phenotype LpS4 is associated with low serum Lp(a) concentrations in Koreans
JQ Kim, JH Song
Clinical Biochemistry 1994
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
P Cremer, D Nagel, B Labrot, H Mann, R Muche, H Elster, D Seidel
European Journal of Clinical Investigation 1994
Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease
MA Austin, JE Hokanson
Medical Clinics of North America 1994
Lipoprotein disorders in diabetes mellitus
WV Brown
Medical Clinics of North America 1994
High-Level Expression of Various Apolipoprotein (a) Isoforms by "Transferrinfection": The Role of Kringle IV Sequences in the Extracellular Association with Low-Density Lipoprotein
S Frank, K Krasznai, S Durovic, EM Lobentanz, H Dieplinger, E Wagner, K Zatloukal, M Cotten, G Utermann
Biochemistry 1994
Structural Domains of Apolipoprotein(a) and Its Interaction with Apolipoprotein B-100 in the Lipoprotein(a) Particle
T Huby, C Doucet, H Dieplinger, J Chapman, J Thillet
Biochemistry 1994
Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients
N Azrolan, CD Brown, L Thomas, T Hayek, ZH Zhao, KG Roberts, C Scheiner, EA Friedman
Arteriosclerosis Thrombosis and Vascular Biology 1994
Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease
F Kronenberg, H Kathrein, P König, U Neyer, W Sturm, K Lhotta, E Gröchenig, G Utermann, H Dieplinger
Arteriosclerosis Thrombosis and Vascular Biology 1994
Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation
F Kronenberg, P König, K Lhotta, D Ofner, C Sandholzer, R Margreiter, E Dosch, G Utermann, H Dieplinger
Arteriosclerosis Thrombosis and Vascular Biology 1994
Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men
SM Haffner, L Mykkanen, KK Gruber, DL Rainwater, M Laakso
Arteriosclerosis Thrombosis and Vascular Biology 1994
Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease
S Islam, B Gutin, C Smith, F Treiber, MI Kamboh
Arteriosclerosis Thrombosis and Vascular Biology 1994
Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms
M Farrer, FL Game, CJ Albers, HA Neil, PH Winocour, MF Laker, PC Adams, KG Alberti
Arteriosclerosis Thrombosis and Vascular Biology 1994
Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women
CJ Kim, HC Jang, DH Cho, YK Min
Arteriosclerosis Thrombosis and Vascular Biology 1994
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg
1994
Principles and Treatment of Lipoprotein Disorders
G Schettler, AJ Habenicht
1994
Women’s Health in Menopause
PG Crosignani, R Paoletti, PM Sarrel, NK Wenger, M Meschia, M Soma
1994
Molecular basis for “null” lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon
AL White, JE Hixson, DL Rainwater, RE Lanford
The Journal of biological chemistry 1994
Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes
AL White, RE Lanford
The Journal of biological chemistry 1994
Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500–>Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins
S Durovic, W Mrz, S Frank, H Scharnagl, MW Baumstark, R Zechner, GM Kostner
The Journal of biological chemistry 1994
Lipoprotein[a] in the chimpanezee: relationship of apo[a] phenotype to elevated plasma Lp[a] levels
C Doucet, T Huby, J Chapman, J Thillet
Journal of lipid research 1994
Apolipoprotein(a) gene transcription is regulated by liver-enriched trans-acting factor hepatocyte nuclear factor 1 alpha
DP Wade, GE Lindahl, RM Lawn
The Journal of biological chemistry 1994
Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia implication for lipoprotein(a) metabolism
G Lindahl, F Mailly, S Humphries, M Seed
The Clinical Investigator 1994
Lipoprotein(a) : new insights into an atherogenic lipoprotein
W Bartens, C Wanner
The Clinical Investigator 1994
Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels
JC Cohen, G Chiesa, HH Hobbs
Journal of Clinical Investigation 1993
Lipoprotein(a) in nephrotic syndrome
P Stenvinkel, L Berglund, O Heimbürger, E Pettersson, A Alvestrand
Kidney International 1993
Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus
K Hirata, S Kikuchi, K Saku, S Jimi, B Zhang, S Naito, H Hamaguchi, K Arakawa
Kidney International 1993
Apolipoprotein (a): A comparison of isoforms identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis or by sodium dodecyl sulfate-agarose gel electrophoresis
WY Craig, SE Poulin, TB Ledue, MI Kamboh
Electrophoresis 1993
Genetics of atherosclerosis: Some strategies for studies of apolipoprotein E
PP Moll
American Journal of Human Biology 1993
5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family
DP Wade, JG Clarke, GE Lindahl, AC Liu, BR Zysow, K Meer, K Schwartz, RM Lawn
Proceedings of the National Academy of Sciences 1993
Plasma predictors of ischemic complications of atherosclerosis: open issues
M Margaglione, E Grandone, GD Minno
Biomedicine & Pharmacotherapy 1993
Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents
DE Wilcken, XL Wang, J Greenwood, J Lynch
The Journal of Pediatrics 1993
Lipoprotein(a) in Patients Treated by Continuous Ambulatory Peritoneal Dialysis
J Thillet, C Faucher, B Issad, M Allouache, J Chapman, C Jacobs
American Journal of Kidney Diseases 1993
Acute myocardial infarction in a young man
RL Duerr, RS Ross
Trends in Cardiovascular Medicine 1993
The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study
SA Brown, JD Morrisett, E Boerwinkle, R Hutchinson, W Patsch
Arteriosclerosis Thrombosis and Vascular Biology 1993
Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients
A von Eckardstein, J Heinrich, H Funke, H Schulte, R Schönfeld, E Köhler, A Steinmetz, G Assmann
Arteriosclerosis Thrombosis and Vascular Biology 1993
Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study
JL Jenner, JM Ordovas, S Lamon-Fava, MM Schaefer, PW Wilson, WP Castelli, EJ Schaefer
Circulation 1993
Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study
SM Marcovina, JJ Albers, DR Jacobs, LL Perkins, CE Lewis, BV Howard, P Savage
Arteriosclerosis Thrombosis and Vascular Biology 1993
Frequent occurrence of familial aggregations of high lipoprotein(a) levels associated with small apolipoprotein(a) isoforms
H Yanagi, A Nakagawa, S Kikuchi, T Tanaka, S Tsuchiya, H Hamaguchi
Human Genetics 1993
High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations
S Kikuchi, A Nakagawa, K Kobayashi, L Li, H Yanagi, T Arinami, Y Kozu, R Miyazaki, S Tsuchiya, H Hamaguchi
Human Genetics 1993
Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease
M Farrer, FL Game, CJ Albers, HA Neil, PH Winocour, MF Laker, PC Adams, KG Alberti
BMJ : British Medical Journal 1993
Serum LP(A) levels in randomized healthy men from different European countries
M Cigolini, JC Seidell, MG Zenti, G Bonadonna, L Zambelli, JP Deslypere, F Contaldo, A Cruz, J Charzewska, G Targher, M Muggeo
European Journal of Epidemiology 1993
Arterial hardening in mice
J Scott
Nature 1992

← Previous 1 2 3 … 27 28 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 11 patents
Referenced in 1 clinical guideline sources
128 readers on Mendeley
1 readers on CiteULike
See more details